Human Gene MIR23B (uc004avg.4) Description and Page Index
  Description: Homo sapiens microRNA 23b (MIR23B), microRNA.
RefSeq Summary (NR_029664): microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]. Sequence Note: This record represents a predicted microRNA stem-loop as defined by miRBase. Some sequence at the 5' and 3' ends may not be included in the intermediate precursor miRNA produced by Drosha cleavage. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications. ##Evidence-Data-START## Transcript is intronless :: LM608479.1, SRR7346977.2684694.1 [ECO:0000345] ##Evidence-Data-END##
Transcript (Including UTRs)
   Position: hg19 chr9:97,847,490-97,848,370 Size: 881 Total Exon Count: 1 Strand: +


Page IndexSequence and LinksCTDRNA-Seq ExpressionMicroarray ExpressionOther Species
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated: 2013-06-14

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr9:97,847,490-97,848,370)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerHGNCLynxOMIM
PubMedStanford SOURCE

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.07 RPKM in Fallopian Tube
Total median expression: 0.07 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  AF043897 - Homo sapiens C90RF3 large isoform, mRNA sequence.
CS266343 - Sequence 35 from Patent WO2005118806.
DL076505 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004155 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261083 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763585 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525890 - Nucleic acid controling mast cell degranulation.
FW421497 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304484 - JP 2009531018-A/51: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304982 - JP 2009531019-A/51: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW102003 - JP 2013500034-A/130: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119191 - JP 2013046612-A/51: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367368 - JP 2012228254-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411761 - JP 2014000079-A/35: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505250 - JP 2014502606-A/152: MELANOMA TREATMENTS.
HW589520 - JP 2013121348-A/51: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674107 - JP 2014217381-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067049 - JP 2014012020-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408208 - JP 2015528002-A/805: CHIRAL CONTROL.
HZ413324 - JP 2014060993-A/51: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427473 - JP 2014217384-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428276 - JP 2014217385-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429079 - JP 2014217386-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429882 - JP 2014217387-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ461520 - WO 2015190586-A/333: Kit and method for detecting colon cancer.
HZ462370 - WO 2015190591-A/525: Kit and method for detecting breast cancer.
HZ463260 - WO 2015194535-A/354: Kit and method for detecting stomach cancer.
HZ464568 - WO 2015194615-A/386: Kit or device and method for detecting hepatic cancer.
HZ465343 - WO 2015194627-A/396: Kit and method for detecting esophageal cancer.
HZ501535 - JP 2016025853-A/51: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769139 - JP 2014223080-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058533 - Sequence 35 from Patent EP2298893.
JA059336 - Sequence 35 from Patent EP2298894.
JA073659 - Sequence 35 from Patent EP2281887.
JA104796 - Sequence 35 from Patent EP2302051.
JA106136 - Sequence 35 from Patent EP2302052.
JA106939 - Sequence 35 from Patent EP2302053.
JA107742 - Sequence 35 from Patent EP2302054.
JA108545 - Sequence 35 from Patent EP2302055.
JA109348 - Sequence 35 from Patent EP2302056.
JA191864 - Sequence 35 from Patent EP2290066.
JA192763 - Sequence 35 from Patent EP2290067.
JA193662 - Sequence 35 from Patent EP2290068.
JA194561 - Sequence 35 from Patent EP2290069.
JA195460 - Sequence 35 from Patent EP2290070.
JA196359 - Sequence 35 from Patent EP2290071.
JA197258 - Sequence 35 from Patent EP2290072.
JA198157 - Sequence 35 from Patent EP2290073.
JA199056 - Sequence 35 from Patent EP2290074.
JA199955 - Sequence 35 from Patent EP2290075.
JA200854 - Sequence 35 from Patent EP2290076.
JA217976 - Sequence 35 from Patent EP2281888.
JA226127 - Sequence 35 from Patent EP2292755.
JA228982 - Sequence 35 from Patent EP2292756.
JA257253 - Sequence 35 from Patent EP2284265.
JA278533 - Sequence 35 from Patent EP2281886.
JA284419 - Sequence 35 from Patent EP2281889.
JA292472 - Sequence 35 from Patent EP2287303.
JA317658 - Sequence 35 from Patent EP2314688.
JA374717 - Sequence 35 from Patent EP2322616.
JA525901 - Sequence 51 from Patent EP2369011.
JA526408 - Sequence 51 from Patent EP2369012.
JA526915 - Sequence 51 from Patent EP2369013.
JA535844 - Sequence 51 from Patent EP2371971.
JA787849 - Sequence 51 from Patent EP2479285.
JA788347 - Sequence 51 from Patent EP2479286.
JA810681 - Sequence 51 from Patent EP2468890.
JA811179 - Sequence 51 from Patent EP2468891.
JA811677 - Sequence 51 from Patent EP2468893.
JA812175 - Sequence 51 from Patent EP2468894.
JA812673 - Sequence 51 from Patent EP2468895.
JA813171 - Sequence 51 from Patent EP2468896.
JA813669 - Sequence 51 from Patent EP2468897.
JA814167 - Sequence 51 from Patent EP2468898.
JA814665 - Sequence 51 from Patent EP2468899.
JA816908 - Sequence 51 from Patent EP2468892.
JA825720 - Sequence 51 from Patent EP2471956.
JA826218 - Sequence 51 from Patent EP2471958.
JB024505 - Sequence 51 from Patent EP2505668.
JB025003 - Sequence 51 from Patent EP2505669.
JB079390 - Sequence 51 from Patent EP2487252.
JB079888 - Sequence 51 from Patent EP2487253.
JB080386 - Sequence 51 from Patent EP2487254.
JB080884 - Sequence 51 from Patent EP2487255.
JB081382 - Sequence 51 from Patent EP2487256.
JB081880 - Sequence 51 from Patent EP2487257.
JB082378 - Sequence 51 from Patent EP2487258.
JB082876 - Sequence 51 from Patent EP2487259.
JB083374 - Sequence 51 from Patent EP2487260.
JB083872 - Sequence 51 from Patent EP2487261.
JB084370 - Sequence 51 from Patent EP2487262.
JB084868 - Sequence 51 from Patent EP2487263.
JB087546 - Sequence 51 from Patent EP2502630.
JB147750 - Sequence 51 from Patent EP2484782.
JB148248 - Sequence 51 from Patent EP2484783.
JB152973 - Sequence 51 from Patent EP2514433.
JB153471 - Sequence 51 from Patent EP2514434.
JB622060 - Sequence 51 from Patent EP2586454.
JB622558 - Sequence 51 from Patent EP2586455.
JC001621 - Sequence 51 from Patent EP2591794.
JC221560 - Sequence 35 from Patent EP2471923.
JC268126 - Sequence 35 from Patent EP2471924.
JC340434 - Sequence 35 from Patent EP2471922.
JC469680 - Sequence 35 from Patent EP2471921.
JC990469 - Sequence 35 from Patent EP2808390.
LF714572 - JP 2016165292-A/35: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856506 - JP 2015142597-A/35: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051542 - KR 1020150036642-A/808: CHIRAL CONTROL.
LQ485240 - Sequence 3 from Patent WO2016113233.
LY496526 - KR 1020170018406-A/396: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497163 - KR 1020170016485-A/333: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498469 - KR 1020170018411-A/386: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499373 - KR 1020170018412-A/525: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY500073 - KR 1020170019425-A/354: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238667 - WO 2017171048-A/328: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MA149454 - JP 2018502567-A/3: METHODS FOR THE DIAGNOSIS OF PANCREATIC CANCER.
MS880688 - Sequence 525 from Patent EP3156498.
MS884350 - Sequence 333 from Patent EP3156499.
MS885192 - Sequence 354 from Patent EP3156503.
MS994534 - Sequence 396 from Patent EP3159406.
CS266534 - Sequence 226 from Patent WO2005118806.
DL076696 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004346 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421688 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367559 - JP 2012228254-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411952 - JP 2014000079-A/226: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674298 - JP 2014217381-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067240 - JP 2014012020-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427664 - JP 2014217384-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428467 - JP 2014217385-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429270 - JP 2014217386-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430073 - JP 2014217387-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769330 - JP 2014223080-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058724 - Sequence 226 from Patent EP2298893.
JA059527 - Sequence 226 from Patent EP2298894.
JA073850 - Sequence 226 from Patent EP2281887.
JA104987 - Sequence 226 from Patent EP2302051.
JA106327 - Sequence 226 from Patent EP2302052.
JA107130 - Sequence 226 from Patent EP2302053.
JA107933 - Sequence 226 from Patent EP2302054.
JA108736 - Sequence 226 from Patent EP2302055.
JA109539 - Sequence 226 from Patent EP2302056.
JA192055 - Sequence 226 from Patent EP2290066.
JA192954 - Sequence 226 from Patent EP2290067.
JA193853 - Sequence 226 from Patent EP2290068.
JA194752 - Sequence 226 from Patent EP2290069.
JA195651 - Sequence 226 from Patent EP2290070.
JA196550 - Sequence 226 from Patent EP2290071.
JA197449 - Sequence 226 from Patent EP2290072.
JA198348 - Sequence 226 from Patent EP2290073.
JA199247 - Sequence 226 from Patent EP2290074.
JA200146 - Sequence 226 from Patent EP2290075.
JA201045 - Sequence 226 from Patent EP2290076.
JA218167 - Sequence 226 from Patent EP2281888.
JA226318 - Sequence 226 from Patent EP2292755.
JA229173 - Sequence 226 from Patent EP2292756.
JA257444 - Sequence 226 from Patent EP2284265.
JA278724 - Sequence 226 from Patent EP2281886.
JA284610 - Sequence 226 from Patent EP2281889.
JA292663 - Sequence 226 from Patent EP2287303.
JA317849 - Sequence 226 from Patent EP2314688.
JA374908 - Sequence 226 from Patent EP2322616.
JC221751 - Sequence 226 from Patent EP2471923.
JC268317 - Sequence 226 from Patent EP2471924.
JC340625 - Sequence 226 from Patent EP2471922.
JC469871 - Sequence 226 from Patent EP2471921.
JC990660 - Sequence 226 from Patent EP2808390.
LF714763 - JP 2016165292-A/226: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856697 - JP 2015142597-A/226: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
FW364157 - Oligonucleotides for modulating target RNA activity.
HI560835 - Sequence 50 from Patent EP2190992.
HI965245 - Sequence 530 from Patent WO2010139812.
HI965891 - Sequence 211 from Patent WO2010139811.
HI966757 - Sequence 211 from Patent WO2010139810.
HV593936 - JP 2010538653-A/50: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595061 - JP 2010539959-A/442: Micromirs.
HW101951 - JP 2013500034-A/78: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505581 - JP 2014502606-A/483: MELANOMA TREATMENTS.
HZ074071 - JP 2013535982-A/162: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083153 - JP 2015513906-A/510: Stem Cell Microparticles.
HZ157618 - JP 2015130862-A/442: Micromirs.
HZ186470 - JP 2015146814-A/219: Oligonucleotides for modulating target RNA activity.
HZ436934 - JP 2015529450-A/510: Stem Cell Microparticles.
HZ479998 - JP 2015535430-A/504: TERMINALLY MODIFIED RNA.
HZ789929 - JP 2016504050-A/1674: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287396 - Sequence 78 from Patent WO2011015720.
JA401283 - Sequence 530 from Patent WO2011080318.
JA402261 - Sequence 530 from Patent WO2011080315.
JA403268 - Sequence 530 from Patent WO2011080316.
JA405899 - Sequence 530 from Patent EP2336353.
JA427168 - Sequence 501 from Patent WO2011072177.
JA429425 - Sequence 530 from Patent WO2011095623.
JA660614 - Sequence 68 from Patent WO2011131354.
JB620247 - Sequence 227 from Patent WO2013063544.
JB624230 - Sequence 50 from Patent EP2610342.
JC172138 - Sequence 510 from Patent WO2013150303.
JC244420 - Sequence 40 from Patent WO2012020308.
JC512661 - Sequence 2914 from Patent WO2014113089.
JC572949 - Sequence 510 from Patent WO2014125276.
JC582637 - Sequence 510 from Patent WO2014125277.
JE954333 - Sequence 510 from Patent WO2015052526.
JE956086 - Sequence 510 from Patent WO2015052527.
JE978623 - Sequence 68 from Patent EP2865765.
LF137838 - JP 2016507550-A/510: Method of Producing Microparticles.
LF161554 - JP 2016513950-A/1620: Oligomers with improved off-target profile.
LF162803 - JP 2016513095-A/510: Stem Cell Microparticles and miRNA.
LF953555 - JP 2016534103-A/510: Stem Cell Microparticles and miRNA.
LG005900 - KR 1020150004822-A/510: STEM CELL MICROPARTICLES.
LG053596 - KR 1020150059168-A/510: STEM CELL MICROPARTICLES.
LG240835 - KR 1020160035087-A/510: STEM CELL MICROPARTICLES AND MIRNA.
LP726517 - Sequence 211 from Patent EP2883966.
LP818787 - Sequence 211 from Patent EP3296406.
LP938729 - Sequence 211 from Patent EP3184651.
LQ070249 - Sequence 573 from Patent EP2964234.
LQ485245 - Sequence 8 from Patent WO2016113233.
LV470920 - JP 2016534036-A/510: Stem Cell Microparticles and miRNA.
LY405126 - KR 1020160117535-A/431: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233827 - JP 2017184756-A/219: Oligonucleotides for modulating target RNA activity.
MA149459 - JP 2018502567-A/8: METHODS FOR THE DIAGNOSIS OF PANCREATIC CANCER.
MA260365 - JP 2017505623-A/431: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS833345 - Sequence 50 from Patent EP3112464.
MS834384 - Sequence 530 from Patent EP3112479.
JD027559 - Sequence 8583 from Patent EP1572962.
MS816716 - Sequence 65 from Patent WO2017085287.
HZ461733 - WO 2015190586-A/546: Kit and method for detecting colon cancer.
HZ462674 - WO 2015190591-A/829: Kit and method for detecting breast cancer.
HZ463473 - WO 2015194535-A/567: Kit and method for detecting stomach cancer.
HZ464810 - WO 2015194615-A/628: Kit or device and method for detecting hepatic cancer.
HZ465575 - WO 2015194627-A/628: Kit and method for detecting esophageal cancer.
LY496758 - KR 1020170018406-A/628: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497376 - KR 1020170016485-A/546: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498711 - KR 1020170018411-A/628: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499677 - KR 1020170018412-A/829: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY500286 - KR 1020170019425-A/567: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238938 - WO 2017171048-A/599: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS880992 - Sequence 829 from Patent EP3156498.
MS884563 - Sequence 546 from Patent EP3156499.
MS885405 - Sequence 567 from Patent EP3156503.
MS994766 - Sequence 628 from Patent EP3159406.
CS548367 - Sequence 1397 from Patent EP1777301.
FV524336 - Nucleic acid controling mast cell degranulation.
FW312108 - DETECTING NUCLEIC ACIDS.
FW364156 - Oligonucleotides for modulating target RNA activity.
FZ414351 - WO 2011007815-A/241: A method for screening a food which promotes production of milk having immunoregulating effect.
HI416796 - Sequence 8 from Patent EP2136846.
HI528948 - Sequence 28 from Patent EP2142659.
HI965246 - Sequence 531 from Patent WO2010139812.
HI965798 - Sequence 118 from Patent WO2010139811.
HI966664 - Sequence 118 from Patent WO2010139810.
HV036106 - WO 2011027893-A/37: A method for predicting the efficacy of chronic hepatitis C treatment.
HV543928 - JP 2011217617-A/39: Method for testing fibrosis of chronic liver diseases using miRNAs.
HV595060 - JP 2010539959-A/441: Micromirs.
HV821879 - JP 2011140513-A/241: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV953938 - JP 2012518421-A/850: METHODS OF DETECTING LUNG CANCER.
HW064993 - JP 2012528797-A/5: Therapeutic and diagnostic molecules.
HW101899 - JP 2013500034-A/26: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW413599 - WO 2014003053-A/48: Method for screening pancreatic cancer and test kit therefor.
HW505439 - JP 2014502606-A/341: MELANOMA TREATMENTS.
HW608525 - JP 2014515024-A/14: Micro-RNA Inhibitors and Their Uses in Disease.
HW799111 - WO 2014192907-A/217: Method for detecting miRNA used for differentiating disorders causing motor neuropathy.
HW906817 - WO 2015037656-A/32: Autophagy-regulating microRNA.
HW913462 - JP 2015504307-A/222: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HW915070 - JP 2015504655-A/28: METHODS FOR DIAGNOSIS AND THERAPEUTIC FOLLOW-UP OF MUSCULAR DYSTROPHIES.
HZ043389 - JP 2015510401-A/479: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.
HZ074072 - JP 2013535982-A/163: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082015 - JP 2015514392-A/479: MicroRNAS FOR THE GENERATION OF ASTROCYTES.
HZ082702 - JP 2015513906-A/59: Stem Cell Microparticles.
HZ157617 - JP 2015130862-A/441: Micromirs.
HZ184843 - JP 2015143222-A/5: Therapeutic and diagnostic molecules.
HZ186469 - JP 2015146814-A/218: Oligonucleotides for modulating target RNA activity.
HZ436483 - JP 2015529450-A/59: Stem Cell Microparticles.
HZ461328 - WO 2015190586-A/141: Kit and method for detecting colon cancer.
HZ462095 - WO 2015190591-A/250: Kit and method for detecting breast cancer.
HZ463062 - WO 2015194535-A/156: Kit and method for detecting stomach cancer.
HZ464350 - WO 2015194615-A/168: Kit or device and method for detecting hepatic cancer.
HZ465133 - WO 2015194627-A/186: Kit and method for detecting esophageal cancer.
HZ479997 - JP 2015535430-A/503: TERMINALLY MODIFIED RNA.
HZ789928 - JP 2016504050-A/1673: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287344 - Sequence 26 from Patent WO2011015720.
JA401284 - Sequence 531 from Patent WO2011080318.
JA402262 - Sequence 531 from Patent WO2011080315.
JA403269 - Sequence 531 from Patent WO2011080316.
JA405900 - Sequence 531 from Patent EP2336353.
JA427076 - Sequence 409 from Patent WO2011072177.
JA429426 - Sequence 531 from Patent WO2011095623.
JA660756 - Sequence 210 from Patent WO2011131354.
JA682648 - Sequence 116 from Patent WO2011149354.
JA715068 - Sequence 850 from Patent EP2401406.
JA778977 - Sequence 8 from Patent EP2419522.
JA878991 - Sequence 6 from Patent EP2460877.
JB022210 - Sequence 52 from Patent WO2013026685.
JB023037 - Sequence 291 from Patent WO2013026684.
JB029504 - Sequence 28 from Patent EP2481805.
JB029564 - Sequence 28 from Patent EP2481806.
JB050032 - Sequence 119 from Patent WO2013020926.
JB074983 - Sequence 243 from Patent WO2012168448.
JB136727 - Sequence 37 from Patent EP2476758.
JB149166 - Sequence 241 from Patent EP2455486.
JB158026 - Sequence 14 from Patent WO2012142313.
JB175303 - Sequence 335 from Patent WO2012101219.
JB358418 - Sequence 5 from Patent EP2438167.
JB616183 - Sequence 13 from Patent WO2013107459.
JB620248 - Sequence 228 from Patent WO2013063544.
JB624144 - Sequence 28 from Patent EP2610347.
JB751146 - Sequence 28 from Patent WO2013087907.
JB778843 - Sequence 222 from Patent WO2013078283.
JC017568 - Sequence 6 from Patent WO2013093870.
JC037765 - Sequence 293 from Patent EP2643479.
JC171687 - Sequence 59 from Patent WO2013150303.
JC244421 - Sequence 41 from Patent WO2012020308.
JC334199 - Sequence 117 from Patent EP2487240.
JC512660 - Sequence 2913 from Patent WO2014113089.
JC572498 - Sequence 59 from Patent WO2014125276.
JC582186 - Sequence 59 from Patent WO2014125277.
JE844305 - Sequence 48 from Patent WO2015091897.
JE953882 - Sequence 59 from Patent WO2015052526.
JE955635 - Sequence 59 from Patent WO2015052527.
JE978765 - Sequence 210 from Patent EP2865765.
JE998670 - Sequence 14 from Patent WO2015115923.
LF137387 - JP 2016507550-A/59: Method of Producing Microparticles.
LF160516 - JP 2016513950-A/582: Oligomers with improved off-target profile.
LF162352 - JP 2016513095-A/59: Stem Cell Microparticles and miRNA.
LF401862 - JP 2015502976-A/6: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LF636247 - JP 2016519076-A/21: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953104 - JP 2016534103-A/59: Stem Cell Microparticles and miRNA.
LG005449 - KR 1020150004822-A/59: STEM CELL MICROPARTICLES.
LG053145 - KR 1020150059168-A/59: STEM CELL MICROPARTICLES.
LG134404 - KR 1020150131312-A/21: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240384 - KR 1020160035087-A/59: STEM CELL MICROPARTICLES AND MIRNA.
LP636965 - Sequence 15 from Patent EP2848702.
LP643867 - Sequence 25 from Patent WO2015091892.
LP715484 - Sequence 5 from Patent WO2016001030.
LP726424 - Sequence 118 from Patent EP2883966.
LP769534 - Sequence 61 from Patent EP3294910.
LP818694 - Sequence 118 from Patent EP3296406.
LP895672 - Sequence 536 from Patent EP3253886.
LP938636 - Sequence 118 from Patent EP3184651.
LP951634 - Sequence 140 from Patent WO2017157650.
LQ070248 - Sequence 572 from Patent EP2964234.
LQ278667 - Sequence 206 from Patent WO2016066288.
LQ420470 - Sequence 46 from Patent WO2016127998.
LQ441236 - Sequence 243 from Patent EP3029157.
LQ485246 - Sequence 9 from Patent WO2016113233.
LQ664853 - Sequence 42 from Patent WO2016150475.
LV470469 - JP 2016534036-A/59: Stem Cell Microparticles and miRNA.
LV539158 - JP 2016539127-A/159: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LY298560 - KR 1020160079824-A/159: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY405125 - KR 1020160117535-A/430: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY496316 - KR 1020170018406-A/186: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY496971 - KR 1020170016485-A/141: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498251 - KR 1020170018411-A/168: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY499098 - KR 1020170018412-A/250: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER.
LY499875 - KR 1020170019425-A/156: STOMACH CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY504614 - KR 1020170035932-A/3: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ231619 - JP 2017186339-A/6: MICRORNAS FOR CARDIAC REGENERATION THROUGH INDUCTION OF CARDIAC MYOCYTE PROLIFERATION.
LZ233826 - JP 2017184756-A/218: Oligonucleotides for modulating target RNA activity.
LZ238415 - WO 2017171048-A/76: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
LZ242895 - JP 2017525350-A/3: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA149460 - JP 2018502567-A/9: METHODS FOR THE DIAGNOSIS OF PANCREATIC CANCER.
MA260364 - JP 2017505623-A/430: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673488 - Sequence 291 from Patent EP3135774.
MS834385 - Sequence 531 from Patent EP3112479.
MS880413 - Sequence 250 from Patent EP3156498.
MS884158 - Sequence 141 from Patent EP3156499.
MS884994 - Sequence 156 from Patent EP3156503.
MS901579 - Sequence 52 from Patent EP3156505.
MS944747 - Sequence 3 from Patent EP3177739.
MS994324 - Sequence 186 from Patent EP3159406.
JD035455 - Sequence 16479 from Patent EP1572962.
DJ003812 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027091 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ442987 - METHOD FOR DETECTING ncRNA.
FU261368 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763870 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304769 - JP 2009531018-A/336: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305267 - JP 2009531019-A/336: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119476 - JP 2013046612-A/336: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589805 - JP 2013121348-A/336: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413609 - JP 2014060993-A/336: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501820 - JP 2016025853-A/336: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526186 - Sequence 336 from Patent EP2369011.
JA526693 - Sequence 336 from Patent EP2369012.
JA527200 - Sequence 336 from Patent EP2369013.
JA536129 - Sequence 336 from Patent EP2371971.
JA788134 - Sequence 336 from Patent EP2479285.
JA788632 - Sequence 336 from Patent EP2479286.
JA810966 - Sequence 336 from Patent EP2468890.
JA811464 - Sequence 336 from Patent EP2468891.
JA811962 - Sequence 336 from Patent EP2468893.
JA812460 - Sequence 336 from Patent EP2468894.
JA812958 - Sequence 336 from Patent EP2468895.
JA813456 - Sequence 336 from Patent EP2468896.
JA813954 - Sequence 336 from Patent EP2468897.
JA814452 - Sequence 336 from Patent EP2468898.
JA814950 - Sequence 336 from Patent EP2468899.
JA817193 - Sequence 336 from Patent EP2468892.
JA826005 - Sequence 336 from Patent EP2471956.
JA826503 - Sequence 336 from Patent EP2471958.
JB024790 - Sequence 336 from Patent EP2505668.
JB025288 - Sequence 336 from Patent EP2505669.
JB079675 - Sequence 336 from Patent EP2487252.
JB080173 - Sequence 336 from Patent EP2487253.
JB080671 - Sequence 336 from Patent EP2487254.
JB081169 - Sequence 336 from Patent EP2487255.
JB081667 - Sequence 336 from Patent EP2487256.
JB082165 - Sequence 336 from Patent EP2487257.
JB082663 - Sequence 336 from Patent EP2487258.
JB083161 - Sequence 336 from Patent EP2487259.
JB083659 - Sequence 336 from Patent EP2487260.
JB084157 - Sequence 336 from Patent EP2487261.
JB084655 - Sequence 336 from Patent EP2487262.
JB085153 - Sequence 336 from Patent EP2487263.
JB087831 - Sequence 336 from Patent EP2502630.
JB148035 - Sequence 336 from Patent EP2484782.
JB148533 - Sequence 336 from Patent EP2484783.
JB153258 - Sequence 336 from Patent EP2514433.
JB153756 - Sequence 336 from Patent EP2514434.
JB622345 - Sequence 336 from Patent EP2586454.
JB622843 - Sequence 336 from Patent EP2586455.
JC001906 - Sequence 336 from Patent EP2591794.
JD026516 - Sequence 7540 from Patent EP1572962.
JD034048 - Sequence 15072 from Patent EP1572962.
CS266351 - Sequence 43 from Patent WO2005118806.
DI443446 - KR 1020140074997-A/67: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DL076513 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004163 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM119445 - Targeting Cells With Altered miRNA Expression.
DM175366 - A nucleics Acid regulating cell growth.
FU261096 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763598 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525891 - Nucleic acid controling mast cell degranulation.
FW421505 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304497 - JP 2009531018-A/64: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304995 - JP 2009531019-A/64: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV322848 - WO 2011040613-A/2: Therapeutic Agent for Tumor.
HW102007 - JP 2013500034-A/134: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119204 - JP 2013046612-A/64: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367376 - JP 2012228254-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411769 - JP 2014000079-A/43: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505227 - JP 2014502606-A/129: MELANOMA TREATMENTS.
HW589533 - JP 2013121348-A/64: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674115 - JP 2014217381-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW800021 - JP 2014530803-A/82: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
HW807772 - JP 2014534810-A/67: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ067057 - JP 2014012020-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408217 - JP 2015528002-A/814: CHIRAL CONTROL.
HZ413337 - JP 2014060993-A/64: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427481 - JP 2014217384-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428284 - JP 2014217385-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429087 - JP 2014217386-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429890 - JP 2014217387-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501548 - JP 2016025853-A/64: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769147 - JP 2014223080-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058541 - Sequence 43 from Patent EP2298893.
JA059344 - Sequence 43 from Patent EP2298894.
JA073667 - Sequence 43 from Patent EP2281887.
JA104804 - Sequence 43 from Patent EP2302051.
JA106144 - Sequence 43 from Patent EP2302052.
JA106947 - Sequence 43 from Patent EP2302053.
JA107750 - Sequence 43 from Patent EP2302054.
JA108553 - Sequence 43 from Patent EP2302055.
JA109356 - Sequence 43 from Patent EP2302056.
JA191872 - Sequence 43 from Patent EP2290066.
JA192771 - Sequence 43 from Patent EP2290067.
JA193670 - Sequence 43 from Patent EP2290068.
JA194569 - Sequence 43 from Patent EP2290069.
JA195468 - Sequence 43 from Patent EP2290070.
JA196367 - Sequence 43 from Patent EP2290071.
JA197266 - Sequence 43 from Patent EP2290072.
JA198165 - Sequence 43 from Patent EP2290073.
JA199064 - Sequence 43 from Patent EP2290074.
JA199963 - Sequence 43 from Patent EP2290075.
JA200862 - Sequence 43 from Patent EP2290076.
JA217984 - Sequence 43 from Patent EP2281888.
JA226135 - Sequence 43 from Patent EP2292755.
JA228990 - Sequence 43 from Patent EP2292756.
JA257261 - Sequence 43 from Patent EP2284265.
JA278541 - Sequence 43 from Patent EP2281886.
JA284427 - Sequence 43 from Patent EP2281889.
JA292480 - Sequence 43 from Patent EP2287303.
JA317666 - Sequence 43 from Patent EP2314688.
JA374725 - Sequence 43 from Patent EP2322616.
JA525914 - Sequence 64 from Patent EP2369011.
JA526421 - Sequence 64 from Patent EP2369012.
JA526928 - Sequence 64 from Patent EP2369013.
JA535857 - Sequence 64 from Patent EP2371971.
JA787862 - Sequence 64 from Patent EP2479285.
JA788360 - Sequence 64 from Patent EP2479286.
JA810694 - Sequence 64 from Patent EP2468890.
JA811192 - Sequence 64 from Patent EP2468891.
JA811690 - Sequence 64 from Patent EP2468893.
JA812188 - Sequence 64 from Patent EP2468894.
JA812686 - Sequence 64 from Patent EP2468895.
JA813184 - Sequence 64 from Patent EP2468896.
JA813682 - Sequence 64 from Patent EP2468897.
JA814180 - Sequence 64 from Patent EP2468898.
JA814678 - Sequence 64 from Patent EP2468899.
JA816921 - Sequence 64 from Patent EP2468892.
JA825733 - Sequence 64 from Patent EP2471956.
JA826231 - Sequence 64 from Patent EP2471958.
JB024518 - Sequence 64 from Patent EP2505668.
JB025016 - Sequence 64 from Patent EP2505669.
JB025717 - Sequence 2 from Patent EP2486929.
JB079403 - Sequence 64 from Patent EP2487252.
JB079901 - Sequence 64 from Patent EP2487253.
JB080399 - Sequence 64 from Patent EP2487254.
JB080897 - Sequence 64 from Patent EP2487255.
JB081395 - Sequence 64 from Patent EP2487256.
JB081893 - Sequence 64 from Patent EP2487257.
JB082391 - Sequence 64 from Patent EP2487258.
JB082889 - Sequence 64 from Patent EP2487259.
JB083387 - Sequence 64 from Patent EP2487260.
JB083885 - Sequence 64 from Patent EP2487261.
JB084383 - Sequence 64 from Patent EP2487262.
JB084881 - Sequence 64 from Patent EP2487263.
JB087559 - Sequence 64 from Patent EP2502630.
JB147763 - Sequence 64 from Patent EP2484782.
JB148261 - Sequence 64 from Patent EP2484783.
JB152986 - Sequence 64 from Patent EP2514433.
JB153484 - Sequence 64 from Patent EP2514434.
JB622073 - Sequence 64 from Patent EP2586454.
JB622571 - Sequence 64 from Patent EP2586455.
JC001634 - Sequence 64 from Patent EP2591794.
JC221568 - Sequence 43 from Patent EP2471923.
JC268134 - Sequence 43 from Patent EP2471924.
JC340442 - Sequence 43 from Patent EP2471922.
JC469688 - Sequence 43 from Patent EP2471921.
JC990477 - Sequence 43 from Patent EP2808390.
JE972031 - Sequence 82 from Patent WO2015118537.
LF714580 - JP 2016165292-A/43: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856514 - JP 2015142597-A/43: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051551 - KR 1020150036642-A/817: CHIRAL CONTROL.
LP883673 - Sequence 82 from Patent EP3208338.
LX145705 - JP 2017506228-A/82: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LX245262 - JP 2017095482-A/82: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LZ228171 - JP 2017524341-A/29: HYBRID TRNA/PRE-MIRNA MOLECULES AND METHODS OF USE.
JD025436 - Sequence 6460 from Patent EP1572962.
JD025694 - Sequence 6718 from Patent EP1572962.
CS266542 - Sequence 234 from Patent WO2005118806.
DL076704 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004354 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261095 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763597 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW421696 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304496 - JP 2009531018-A/63: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304994 - JP 2009531019-A/63: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119203 - JP 2013046612-A/63: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367567 - JP 2012228254-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411960 - JP 2014000079-A/234: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW589532 - JP 2013121348-A/63: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674306 - JP 2014217381-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067248 - JP 2014012020-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ413336 - JP 2014060993-A/63: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427672 - JP 2014217384-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428475 - JP 2014217385-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429278 - JP 2014217386-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430081 - JP 2014217387-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501547 - JP 2016025853-A/63: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769338 - JP 2014223080-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058732 - Sequence 234 from Patent EP2298893.
JA059535 - Sequence 234 from Patent EP2298894.
JA073858 - Sequence 234 from Patent EP2281887.
JA104995 - Sequence 234 from Patent EP2302051.
JA106335 - Sequence 234 from Patent EP2302052.
JA107138 - Sequence 234 from Patent EP2302053.
JA107941 - Sequence 234 from Patent EP2302054.
JA108744 - Sequence 234 from Patent EP2302055.
JA109547 - Sequence 234 from Patent EP2302056.
JA192063 - Sequence 234 from Patent EP2290066.
JA192962 - Sequence 234 from Patent EP2290067.
JA193861 - Sequence 234 from Patent EP2290068.
JA194760 - Sequence 234 from Patent EP2290069.
JA195659 - Sequence 234 from Patent EP2290070.
JA196558 - Sequence 234 from Patent EP2290071.
JA197457 - Sequence 234 from Patent EP2290072.
JA198356 - Sequence 234 from Patent EP2290073.
JA199255 - Sequence 234 from Patent EP2290074.
JA200154 - Sequence 234 from Patent EP2290075.
JA201053 - Sequence 234 from Patent EP2290076.
JA218175 - Sequence 234 from Patent EP2281888.
JA226326 - Sequence 234 from Patent EP2292755.
JA229181 - Sequence 234 from Patent EP2292756.
JA257452 - Sequence 234 from Patent EP2284265.
JA278732 - Sequence 234 from Patent EP2281886.
JA284618 - Sequence 234 from Patent EP2281889.
JA292671 - Sequence 234 from Patent EP2287303.
JA317857 - Sequence 234 from Patent EP2314688.
JA374916 - Sequence 234 from Patent EP2322616.
JA525913 - Sequence 63 from Patent EP2369011.
JA526420 - Sequence 63 from Patent EP2369012.
JA526927 - Sequence 63 from Patent EP2369013.
JA535856 - Sequence 63 from Patent EP2371971.
JA787861 - Sequence 63 from Patent EP2479285.
JA788359 - Sequence 63 from Patent EP2479286.
JA810693 - Sequence 63 from Patent EP2468890.
JA811191 - Sequence 63 from Patent EP2468891.
JA811689 - Sequence 63 from Patent EP2468893.
JA812187 - Sequence 63 from Patent EP2468894.
JA812685 - Sequence 63 from Patent EP2468895.
JA813183 - Sequence 63 from Patent EP2468896.
JA813681 - Sequence 63 from Patent EP2468897.
JA814179 - Sequence 63 from Patent EP2468898.
JA814677 - Sequence 63 from Patent EP2468899.
JA816920 - Sequence 63 from Patent EP2468892.
JA825732 - Sequence 63 from Patent EP2471956.
JA826230 - Sequence 63 from Patent EP2471958.
JB024517 - Sequence 63 from Patent EP2505668.
JB025015 - Sequence 63 from Patent EP2505669.
JB079402 - Sequence 63 from Patent EP2487252.
JB079900 - Sequence 63 from Patent EP2487253.
JB080398 - Sequence 63 from Patent EP2487254.
JB080896 - Sequence 63 from Patent EP2487255.
JB081394 - Sequence 63 from Patent EP2487256.
JB081892 - Sequence 63 from Patent EP2487257.
JB082390 - Sequence 63 from Patent EP2487258.
JB082888 - Sequence 63 from Patent EP2487259.
JB083386 - Sequence 63 from Patent EP2487260.
JB083884 - Sequence 63 from Patent EP2487261.
JB084382 - Sequence 63 from Patent EP2487262.
JB084880 - Sequence 63 from Patent EP2487263.
JB087558 - Sequence 63 from Patent EP2502630.
JB147762 - Sequence 63 from Patent EP2484782.
JB148260 - Sequence 63 from Patent EP2484783.
JB152985 - Sequence 63 from Patent EP2514433.
JB153483 - Sequence 63 from Patent EP2514434.
JB622072 - Sequence 63 from Patent EP2586454.
JB622570 - Sequence 63 from Patent EP2586455.
JC001633 - Sequence 63 from Patent EP2591794.
JC221759 - Sequence 234 from Patent EP2471923.
JC268325 - Sequence 234 from Patent EP2471924.
JC340633 - Sequence 234 from Patent EP2471922.
JC469879 - Sequence 234 from Patent EP2471921.
JC990668 - Sequence 234 from Patent EP2808390.
LF714771 - JP 2016165292-A/234: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856705 - JP 2015142597-A/234: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
FW364171 - Oligonucleotides for modulating target RNA activity.
HI560851 - Sequence 66 from Patent EP2190992.
HI965231 - Sequence 516 from Patent WO2010139812.
HI966017 - Sequence 337 from Patent WO2010139811.
HI966883 - Sequence 337 from Patent WO2010139810.
HV593952 - JP 2010538653-A/66: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595075 - JP 2010539959-A/456: Micromirs.
HV938844 - JP 2011519579-A/1672: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HW101955 - JP 2013500034-A/82: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505565 - JP 2014502606-A/467: MELANOMA TREATMENTS.
HW913420 - JP 2015504307-A/180: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074073 - JP 2013535982-A/164: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082844 - JP 2015513906-A/201: Stem Cell Microparticles.
HZ157632 - JP 2015130862-A/456: Micromirs.
HZ186484 - JP 2015146814-A/233: Oligonucleotides for modulating target RNA activity.
HZ436625 - JP 2015529450-A/201: Stem Cell Microparticles.
HZ480019 - JP 2015535430-A/525: TERMINALLY MODIFIED RNA.
HZ789950 - JP 2016504050-A/1695: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287400 - Sequence 82 from Patent WO2011015720.
JA401269 - Sequence 516 from Patent WO2011080318.
JA402247 - Sequence 516 from Patent WO2011080315.
JA403254 - Sequence 516 from Patent WO2011080316.
JA405885 - Sequence 516 from Patent EP2336353.
JA426882 - Sequence 215 from Patent WO2011072177.
JA429411 - Sequence 516 from Patent WO2011095623.
JA821151 - Sequence 1672 from Patent EP2285961.
JB620060 - Sequence 40 from Patent WO2013063544.
JB620249 - Sequence 229 from Patent WO2013063544.
JB624246 - Sequence 66 from Patent EP2610342.
JB778801 - Sequence 180 from Patent WO2013078283.
JC171829 - Sequence 201 from Patent WO2013150303.
JC244429 - Sequence 49 from Patent WO2012020308.
JC512682 - Sequence 2935 from Patent WO2014113089.
JC572640 - Sequence 201 from Patent WO2014125276.
JC582328 - Sequence 201 from Patent WO2014125277.
JE954024 - Sequence 201 from Patent WO2015052526.
JE955777 - Sequence 201 from Patent WO2015052527.
LF137529 - JP 2016507550-A/201: Method of Producing Microparticles.
LF161723 - JP 2016513950-A/1789: Oligomers with improved off-target profile.
LF162494 - JP 2016513095-A/201: Stem Cell Microparticles and miRNA.
LF953246 - JP 2016534103-A/201: Stem Cell Microparticles and miRNA.
LG005591 - KR 1020150004822-A/201: STEM CELL MICROPARTICLES.
LG053287 - KR 1020150059168-A/201: STEM CELL MICROPARTICLES.
LG240526 - KR 1020160035087-A/201: STEM CELL MICROPARTICLES AND MIRNA.
LP726643 - Sequence 337 from Patent EP2883966.
LP818913 - Sequence 337 from Patent EP3296406.
LP938855 - Sequence 337 from Patent EP3184651.
LQ070270 - Sequence 594 from Patent EP2964234.
LV470611 - JP 2016534036-A/201: Stem Cell Microparticles and miRNA.
LY405140 - KR 1020160117535-A/445: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233841 - JP 2017184756-A/233: Oligonucleotides for modulating target RNA activity.
MA260379 - JP 2017505623-A/445: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS816814 - Sequence 163 from Patent WO2017085287.
MS833361 - Sequence 66 from Patent EP3112464.
MS834370 - Sequence 516 from Patent EP3112479.
DJ003817 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027096 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
FU261374 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763876 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304775 - JP 2009531018-A/342: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305273 - JP 2009531019-A/342: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119482 - JP 2013046612-A/342: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589811 - JP 2013121348-A/342: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413615 - JP 2014060993-A/342: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501826 - JP 2016025853-A/342: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526192 - Sequence 342 from Patent EP2369011.
JA526699 - Sequence 342 from Patent EP2369012.
JA527206 - Sequence 342 from Patent EP2369013.
JA536135 - Sequence 342 from Patent EP2371971.
JA788140 - Sequence 342 from Patent EP2479285.
JA788638 - Sequence 342 from Patent EP2479286.
JA810972 - Sequence 342 from Patent EP2468890.
JA811470 - Sequence 342 from Patent EP2468891.
JA811968 - Sequence 342 from Patent EP2468893.
JA812466 - Sequence 342 from Patent EP2468894.
JA812964 - Sequence 342 from Patent EP2468895.
JA813462 - Sequence 342 from Patent EP2468896.
JA813960 - Sequence 342 from Patent EP2468897.
JA814458 - Sequence 342 from Patent EP2468898.
JA814956 - Sequence 342 from Patent EP2468899.
JA817199 - Sequence 342 from Patent EP2468892.
JA826011 - Sequence 342 from Patent EP2471956.
JA826509 - Sequence 342 from Patent EP2471958.
JB024796 - Sequence 342 from Patent EP2505668.
JB025294 - Sequence 342 from Patent EP2505669.
JB079681 - Sequence 342 from Patent EP2487252.
JB080179 - Sequence 342 from Patent EP2487253.
JB080677 - Sequence 342 from Patent EP2487254.
JB081175 - Sequence 342 from Patent EP2487255.
JB081673 - Sequence 342 from Patent EP2487256.
JB082171 - Sequence 342 from Patent EP2487257.
JB082669 - Sequence 342 from Patent EP2487258.
JB083167 - Sequence 342 from Patent EP2487259.
JB083665 - Sequence 342 from Patent EP2487260.
JB084163 - Sequence 342 from Patent EP2487261.
JB084661 - Sequence 342 from Patent EP2487262.
JB085159 - Sequence 342 from Patent EP2487263.
JB087837 - Sequence 342 from Patent EP2502630.
JB148041 - Sequence 342 from Patent EP2484782.
JB148539 - Sequence 342 from Patent EP2484783.
JB153264 - Sequence 342 from Patent EP2514433.
JB153762 - Sequence 342 from Patent EP2514434.
JB622351 - Sequence 342 from Patent EP2586454.
JB622849 - Sequence 342 from Patent EP2586455.
JC001912 - Sequence 342 from Patent EP2591794.
CS548373 - Sequence 1403 from Patent EP1777301.
DI443445 - KR 1020140074997-A/66: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DM119446 - Targeting Cells With Altered miRNA Expression.
DM174423 - A nucleics Acid regulating cell growth.
FV524337 - Nucleic acid controling mast cell degranulation.
FW312114 - DETECTING NUCLEIC ACIDS.
FW364170 - Oligonucleotides for modulating target RNA activity.
FZ414200 - WO 2011007815-A/90: A method for screening a food which promotes production of milk having immunoregulating effect.
HI560850 - Sequence 65 from Patent EP2190992.
HI965232 - Sequence 517 from Patent WO2010139812.
HI966489 - Sequence 809 from Patent WO2010139811.
HI967355 - Sequence 809 from Patent WO2010139810.
HV036103 - WO 2011027893-A/34: A method for predicting the efficacy of chronic hepatitis C treatment.
HV322847 - WO 2011040613-A/1: Therapeutic Agent for Tumor.
HV540969 - WO 2011125469-A/13: A recombinant vaccinia virus regulated by miRNA and use thereof.
HV593951 - JP 2010538653-A/65: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595074 - JP 2010539959-A/455: Micromirs.
HV821728 - JP 2011140513-A/90: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV938845 - JP 2011519579-A/1673: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation.
HV953945 - JP 2012518421-A/857: METHODS OF DETECTING LUNG CANCER.
HW064990 - JP 2012528797-A/2: Therapeutic and diagnostic molecules.
HW101903 - JP 2013500034-A/30: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW151485 - WO 2013047815-A/30: ENDOPLASMIC RETICULUM STRESS MODULATOR.
HW413605 - WO 2014003053-A/54: Method for screening pancreatic cancer and test kit therefor.
HW505416 - JP 2014502606-A/318: MELANOMA TREATMENTS.
HW523267 - JP 2014507123-A/52: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW800023 - JP 2014530803-A/84: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
HW807771 - JP 2014534810-A/66: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW913294 - JP 2015504307-A/54: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074074 - JP 2013535982-A/165: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082649 - JP 2015513906-A/6: Stem Cell Microparticles.
HZ157631 - JP 2015130862-A/455: Micromirs.
HZ184840 - JP 2015143222-A/2: Therapeutic and diagnostic molecules.
HZ186483 - JP 2015146814-A/232: Oligonucleotides for modulating target RNA activity.
HZ436430 - JP 2015529450-A/6: Stem Cell Microparticles.
HZ480018 - JP 2015535430-A/524: TERMINALLY MODIFIED RNA.
HZ789949 - JP 2016504050-A/1694: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287348 - Sequence 30 from Patent WO2011015720.
JA401270 - Sequence 517 from Patent WO2011080318.
JA402248 - Sequence 517 from Patent WO2011080315.
JA403255 - Sequence 517 from Patent WO2011080316.
JA405886 - Sequence 517 from Patent EP2336353.
JA426914 - Sequence 247 from Patent WO2011072177.
JA429412 - Sequence 517 from Patent WO2011095623.
JA682592 - Sequence 60 from Patent WO2011149354.
JA715075 - Sequence 857 from Patent EP2401406.
JA791711 - Sequence 113 from Patent WO2012089772.
JA821152 - Sequence 1673 from Patent EP2285961.
JA829623 - Sequence 6 from Patent WO2013010906.
JA885422 - Sequence 52 from Patent WO2012083004.
JB025716 - Sequence 1 from Patent EP2486929.
JB050046 - Sequence 133 from Patent WO2013020926.
JB073395 - Sequence 6 from Patent EP2546358.
JB075066 - Sequence 326 from Patent WO2012168448.
JB136724 - Sequence 34 from Patent EP2476758.
JB149015 - Sequence 90 from Patent EP2455486.
JB175073 - Sequence 105 from Patent WO2012101219.
JB358415 - Sequence 2 from Patent EP2438167.
JB406714 - Sequence 40 from Patent WO2012072685.
JB615290 - Sequence 12 from Patent WO2013070079.
JB620250 - Sequence 230 from Patent WO2013063544.
JB624245 - Sequence 65 from Patent EP2610342.
JB778675 - Sequence 54 from Patent WO2013078283.
JC037661 - Sequence 189 from Patent EP2643479.
JC171634 - Sequence 6 from Patent WO2013150303.
JC244878 - Sequence 506 from Patent WO2012020308.
JC244954 - Sequence 582 from Patent WO2012020308.
JC334205 - Sequence 123 from Patent EP2487240.
JC512681 - Sequence 2934 from Patent WO2014113089.
JC572445 - Sequence 6 from Patent WO2014125276.
JC582133 - Sequence 6 from Patent WO2014125277.
JD568352 - Sequence 11 from Patent WO2015007294.
JD568619 - Sequence 9 from Patent WO2015007293.
JE844298 - Sequence 41 from Patent WO2015091897.
JE953829 - Sequence 6 from Patent WO2015052526.
JE955582 - Sequence 6 from Patent WO2015052527.
JE972033 - Sequence 84 from Patent WO2015118537.
JE998672 - Sequence 16 from Patent WO2015115923.
LF137334 - JP 2016507550-A/6: Method of Producing Microparticles.
LF161920 - JP 2016513950-A/1986: Oligomers with improved off-target profile.
LF162299 - JP 2016513095-A/6: Stem Cell Microparticles and miRNA.
LF636242 - JP 2016519076-A/16: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953051 - JP 2016534103-A/6: Stem Cell Microparticles and miRNA.
LG005396 - KR 1020150004822-A/6: STEM CELL MICROPARTICLES.
LG053092 - KR 1020150059168-A/6: STEM CELL MICROPARTICLES.
LG134399 - KR 1020150131312-A/16: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG240331 - KR 1020160035087-A/6: STEM CELL MICROPARTICLES AND MIRNA.
LP636968 - Sequence 18 from Patent EP2848702.
LP727115 - Sequence 809 from Patent EP2883966.
LP769510 - Sequence 37 from Patent EP3294910.
LP819385 - Sequence 809 from Patent EP3296406.
LP883675 - Sequence 84 from Patent EP3208338.
LP895677 - Sequence 541 from Patent EP3253886.
LP917439 - Sequence 35 from Patent WO2017153710.
LP917461 - Sequence 57 from Patent WO2017153710.
LP939327 - Sequence 809 from Patent EP3184651.
LP951606 - Sequence 112 from Patent WO2017157650.
LQ070269 - Sequence 593 from Patent EP2964234.
LQ278686 - Sequence 225 from Patent WO2016066288.
LQ405125 - Sequence 16 from Patent WO2016148593.
LQ420474 - Sequence 50 from Patent WO2016127998.
LQ441319 - Sequence 326 from Patent EP3029157.
LQ565009 - Sequence 34 from Patent WO2016139092.
LQ664858 - Sequence 47 from Patent WO2016150475.
LQ754439 - Sequence 17 from Patent EP3329005.
LQ844115 - Sequence 35 from Patent WO2018138468.
LQ844137 - Sequence 57 from Patent WO2018138468.
LV470416 - JP 2016534036-A/6: Stem Cell Microparticles and miRNA.
LV539146 - JP 2016539127-A/147: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LX145707 - JP 2017506228-A/84: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LX245264 - JP 2017095482-A/84: MICRO-RNAS AND COMPOSITIONS COMPRISING SAME FOR THE TREATMENT AND DIAGNOSIS OF SEROTONIN-, ADRENALIN-, NORADRENALIN-, GLUTAMATE-, AND CORTICOTROPIN-RELEASING HORMONE-ASSOCIATED MEDICAL CONDITIONS.
LY298548 - KR 1020160079824-A/147: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY405139 - KR 1020160117535-A/444: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY416939 - KR 1020160145093-A/45: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY.
LY504733 - KR 1020170035932-A/122: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233840 - JP 2017184756-A/232: Oligonucleotides for modulating target RNA activity.
LZ243014 - JP 2017525350-A/122: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
MA260378 - JP 2017505623-A/444: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS637890 - Sequence 7 from Patent WO2017037190.
MS833360 - Sequence 65 from Patent EP3112464.
MS834371 - Sequence 517 from Patent EP3112479.
MS944866 - Sequence 122 from Patent EP3177739.
JD028371 - Sequence 9395 from Patent EP1572962.
AF043896 - Homo sapiens C90RF3 short isoform, mRNA sequence.
FU261251 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763753 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304652 - JP 2009531018-A/219: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305150 - JP 2009531019-A/219: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119359 - JP 2013046612-A/219: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589688 - JP 2013121348-A/219: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413492 - JP 2014060993-A/219: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501703 - JP 2016025853-A/219: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526069 - Sequence 219 from Patent EP2369011.
JA526576 - Sequence 219 from Patent EP2369012.
JA527083 - Sequence 219 from Patent EP2369013.
JA536012 - Sequence 219 from Patent EP2371971.
JA788017 - Sequence 219 from Patent EP2479285.
JA788515 - Sequence 219 from Patent EP2479286.
JA810849 - Sequence 219 from Patent EP2468890.
JA811347 - Sequence 219 from Patent EP2468891.
JA811845 - Sequence 219 from Patent EP2468893.
JA812343 - Sequence 219 from Patent EP2468894.
JA812841 - Sequence 219 from Patent EP2468895.
JA813339 - Sequence 219 from Patent EP2468896.
JA813837 - Sequence 219 from Patent EP2468897.
JA814335 - Sequence 219 from Patent EP2468898.
JA814833 - Sequence 219 from Patent EP2468899.
JA817076 - Sequence 219 from Patent EP2468892.
JA825888 - Sequence 219 from Patent EP2471956.
JA826386 - Sequence 219 from Patent EP2471958.
JB024673 - Sequence 219 from Patent EP2505668.
JB025171 - Sequence 219 from Patent EP2505669.
JB079558 - Sequence 219 from Patent EP2487252.
JB080056 - Sequence 219 from Patent EP2487253.
JB080554 - Sequence 219 from Patent EP2487254.
JB081052 - Sequence 219 from Patent EP2487255.
JB081550 - Sequence 219 from Patent EP2487256.
JB082048 - Sequence 219 from Patent EP2487257.
JB082546 - Sequence 219 from Patent EP2487258.
JB083044 - Sequence 219 from Patent EP2487259.
JB083542 - Sequence 219 from Patent EP2487260.
JB084040 - Sequence 219 from Patent EP2487261.
JB084538 - Sequence 219 from Patent EP2487262.
JB085036 - Sequence 219 from Patent EP2487263.
JB087714 - Sequence 219 from Patent EP2502630.
JB147918 - Sequence 219 from Patent EP2484782.
JB148416 - Sequence 219 from Patent EP2484783.
JB153141 - Sequence 219 from Patent EP2514433.
JB153639 - Sequence 219 from Patent EP2514434.
JB622228 - Sequence 219 from Patent EP2586454.
JB622726 - Sequence 219 from Patent EP2586455.
JC001789 - Sequence 219 from Patent EP2591794.
AF480560 - Homo sapiens miR-24-precursor-9 micro RNA, complete sequence.
FU261088 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763590 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HV304489 - JP 2009531018-A/56: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304987 - JP 2009531019-A/56: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119196 - JP 2013046612-A/56: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589525 - JP 2013121348-A/56: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ413329 - JP 2014060993-A/56: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501540 - JP 2016025853-A/56: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA525906 - Sequence 56 from Patent EP2369011.
JA526413 - Sequence 56 from Patent EP2369012.
JA526920 - Sequence 56 from Patent EP2369013.
JA535849 - Sequence 56 from Patent EP2371971.
JA787854 - Sequence 56 from Patent EP2479285.
JA788352 - Sequence 56 from Patent EP2479286.
JA810686 - Sequence 56 from Patent EP2468890.
JA811184 - Sequence 56 from Patent EP2468891.
JA811682 - Sequence 56 from Patent EP2468893.
JA812180 - Sequence 56 from Patent EP2468894.
JA812678 - Sequence 56 from Patent EP2468895.
JA813176 - Sequence 56 from Patent EP2468896.
JA813674 - Sequence 56 from Patent EP2468897.
JA814172 - Sequence 56 from Patent EP2468898.
JA814670 - Sequence 56 from Patent EP2468899.
JA816913 - Sequence 56 from Patent EP2468892.
JA825725 - Sequence 56 from Patent EP2471956.
JA826223 - Sequence 56 from Patent EP2471958.
JB024510 - Sequence 56 from Patent EP2505668.
JB025008 - Sequence 56 from Patent EP2505669.
JB079395 - Sequence 56 from Patent EP2487252.
JB079893 - Sequence 56 from Patent EP2487253.
JB080391 - Sequence 56 from Patent EP2487254.
JB080889 - Sequence 56 from Patent EP2487255.
JB081387 - Sequence 56 from Patent EP2487256.
JB081885 - Sequence 56 from Patent EP2487257.
JB082383 - Sequence 56 from Patent EP2487258.
JB082881 - Sequence 56 from Patent EP2487259.
JB083379 - Sequence 56 from Patent EP2487260.
JB083877 - Sequence 56 from Patent EP2487261.
JB084375 - Sequence 56 from Patent EP2487262.
JB084873 - Sequence 56 from Patent EP2487263.
JB087551 - Sequence 56 from Patent EP2502630.
JB147755 - Sequence 56 from Patent EP2484782.
JB148253 - Sequence 56 from Patent EP2484783.
JB152978 - Sequence 56 from Patent EP2514433.
JB153476 - Sequence 56 from Patent EP2514434.
JB622065 - Sequence 56 from Patent EP2586454.
JB622563 - Sequence 56 from Patent EP2586455.
JC001626 - Sequence 56 from Patent EP2591794.
CS266537 - Sequence 229 from Patent WO2005118806.
DL076699 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004349 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421691 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367562 - JP 2012228254-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411955 - JP 2014000079-A/229: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674301 - JP 2014217381-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067243 - JP 2014012020-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427667 - JP 2014217384-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428470 - JP 2014217385-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429273 - JP 2014217386-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430076 - JP 2014217387-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769333 - JP 2014223080-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058727 - Sequence 229 from Patent EP2298893.
JA059530 - Sequence 229 from Patent EP2298894.
JA073853 - Sequence 229 from Patent EP2281887.
JA104990 - Sequence 229 from Patent EP2302051.
JA106330 - Sequence 229 from Patent EP2302052.
JA107133 - Sequence 229 from Patent EP2302053.
JA107936 - Sequence 229 from Patent EP2302054.
JA108739 - Sequence 229 from Patent EP2302055.
JA109542 - Sequence 229 from Patent EP2302056.
JA192058 - Sequence 229 from Patent EP2290066.
JA192957 - Sequence 229 from Patent EP2290067.
JA193856 - Sequence 229 from Patent EP2290068.
JA194755 - Sequence 229 from Patent EP2290069.
JA195654 - Sequence 229 from Patent EP2290070.
JA196553 - Sequence 229 from Patent EP2290071.
JA197452 - Sequence 229 from Patent EP2290072.
JA198351 - Sequence 229 from Patent EP2290073.
JA199250 - Sequence 229 from Patent EP2290074.
JA200149 - Sequence 229 from Patent EP2290075.
JA201048 - Sequence 229 from Patent EP2290076.
JA218170 - Sequence 229 from Patent EP2281888.
JA226321 - Sequence 229 from Patent EP2292755.
JA229176 - Sequence 229 from Patent EP2292756.
JA257447 - Sequence 229 from Patent EP2284265.
JA278727 - Sequence 229 from Patent EP2281886.
JA284613 - Sequence 229 from Patent EP2281889.
JA292666 - Sequence 229 from Patent EP2287303.
JA317852 - Sequence 229 from Patent EP2314688.
JA374911 - Sequence 229 from Patent EP2322616.
JC221754 - Sequence 229 from Patent EP2471923.
JC268320 - Sequence 229 from Patent EP2471924.
JC340628 - Sequence 229 from Patent EP2471922.
JC469874 - Sequence 229 from Patent EP2471921.
JC990663 - Sequence 229 from Patent EP2808390.
LF714766 - JP 2016165292-A/229: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856700 - JP 2015142597-A/229: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
CS266344 - Sequence 36 from Patent WO2005118806.
CS266536 - Sequence 228 from Patent WO2005118806.
DI443423 - KR 1020140074997-A/44: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DL076506 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DL076698 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DL243107 - Agent for controlling growth and/or differentiation of mesenchymal stem cells.
DM004156 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM004348 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
DM119434 - Targeting Cells With Altered miRNA Expression.
DM175359 - A nucleics Acid regulating cell growth.
FU261085 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU261252 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763587 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FU763754 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525812 - Nucleic acid controling mast cell degranulation.
FW418961 - METHOD FOR DISTINGUISHING BETWEEN LUNG SQUAMOUS CARCINOMA AND OTHER NON SMALL CELL LUNG CANCERS.
FW421498 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421690 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HV304486 - JP 2009531018-A/53: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304653 - JP 2009531018-A/220: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV304984 - JP 2009531019-A/53: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV305151 - JP 2009531019-A/220: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119193 - JP 2013046612-A/53: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW119360 - JP 2013046612-A/220: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367369 - JP 2012228254-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367561 - JP 2012228254-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411762 - JP 2014000079-A/36: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW411954 - JP 2014000079-A/228: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505180 - JP 2014502606-A/82: MELANOMA TREATMENTS.
HW505211 - JP 2014502606-A/113: MELANOMA TREATMENTS.
HW589522 - JP 2013121348-A/53: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW589689 - JP 2013121348-A/220: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674108 - JP 2014217381-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW674300 - JP 2014217381-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW807749 - JP 2014534810-A/44: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ067050 - JP 2014012020-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067242 - JP 2014012020-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408210 - JP 2015528002-A/807: CHIRAL CONTROL.
HZ413326 - JP 2014060993-A/53: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ413493 - JP 2014060993-A/220: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427474 - JP 2014217384-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427666 - JP 2014217384-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428277 - JP 2014217385-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428469 - JP 2014217385-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429080 - JP 2014217386-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429272 - JP 2014217386-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429883 - JP 2014217387-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430075 - JP 2014217387-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ459538 - WO 2015182781-A/241: Kit or device and method for detecting pancreatic cancer.
HZ460233 - WO 2015190542-A/239: Kit or device and method for detecting biliary tract cancer.
HZ461559 - WO 2015190586-A/372: Kit and method for detecting colon cancer.
HZ464616 - WO 2015194615-A/434: Kit or device and method for detecting hepatic cancer.
HZ465634 - WO 2015194627-A/687: Kit and method for detecting esophageal cancer.
HZ501537 - JP 2016025853-A/53: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501704 - JP 2016025853-A/220: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769140 - JP 2014223080-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769332 - JP 2014223080-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058534 - Sequence 36 from Patent EP2298893.
JA058726 - Sequence 228 from Patent EP2298893.
JA059337 - Sequence 36 from Patent EP2298894.
JA059529 - Sequence 228 from Patent EP2298894.
JA073660 - Sequence 36 from Patent EP2281887.
JA073852 - Sequence 228 from Patent EP2281887.
JA104797 - Sequence 36 from Patent EP2302051.
JA104989 - Sequence 228 from Patent EP2302051.
JA106137 - Sequence 36 from Patent EP2302052.
JA106329 - Sequence 228 from Patent EP2302052.
JA106940 - Sequence 36 from Patent EP2302053.
JA107132 - Sequence 228 from Patent EP2302053.
JA107743 - Sequence 36 from Patent EP2302054.
JA107935 - Sequence 228 from Patent EP2302054.
JA108546 - Sequence 36 from Patent EP2302055.
JA108738 - Sequence 228 from Patent EP2302055.
JA109349 - Sequence 36 from Patent EP2302056.
JA109541 - Sequence 228 from Patent EP2302056.
JA191865 - Sequence 36 from Patent EP2290066.
JA192057 - Sequence 228 from Patent EP2290066.
JA192764 - Sequence 36 from Patent EP2290067.
JA192956 - Sequence 228 from Patent EP2290067.
JA193663 - Sequence 36 from Patent EP2290068.
JA193855 - Sequence 228 from Patent EP2290068.
JA194562 - Sequence 36 from Patent EP2290069.
JA194754 - Sequence 228 from Patent EP2290069.
JA195461 - Sequence 36 from Patent EP2290070.
JA195653 - Sequence 228 from Patent EP2290070.
JA196360 - Sequence 36 from Patent EP2290071.
JA196552 - Sequence 228 from Patent EP2290071.
JA197259 - Sequence 36 from Patent EP2290072.
JA197451 - Sequence 228 from Patent EP2290072.
JA198158 - Sequence 36 from Patent EP2290073.
JA198350 - Sequence 228 from Patent EP2290073.
JA199057 - Sequence 36 from Patent EP2290074.
JA199249 - Sequence 228 from Patent EP2290074.
JA199956 - Sequence 36 from Patent EP2290075.
JA200148 - Sequence 228 from Patent EP2290075.
JA200855 - Sequence 36 from Patent EP2290076.
JA201047 - Sequence 228 from Patent EP2290076.
JA217977 - Sequence 36 from Patent EP2281888.
JA218169 - Sequence 228 from Patent EP2281888.
JA226128 - Sequence 36 from Patent EP2292755.
JA226320 - Sequence 228 from Patent EP2292755.
JA228983 - Sequence 36 from Patent EP2292756.
JA229175 - Sequence 228 from Patent EP2292756.
JA257254 - Sequence 36 from Patent EP2284265.
JA257446 - Sequence 228 from Patent EP2284265.
JA278534 - Sequence 36 from Patent EP2281886.
JA278726 - Sequence 228 from Patent EP2281886.
JA284420 - Sequence 36 from Patent EP2281889.
JA284612 - Sequence 228 from Patent EP2281889.
JA292473 - Sequence 36 from Patent EP2287303.
JA292665 - Sequence 228 from Patent EP2287303.
JA317659 - Sequence 36 from Patent EP2314688.
JA317851 - Sequence 228 from Patent EP2314688.
JA374718 - Sequence 36 from Patent EP2322616.
JA374910 - Sequence 228 from Patent EP2322616.
JA525903 - Sequence 53 from Patent EP2369011.
JA526070 - Sequence 220 from Patent EP2369011.
JA526410 - Sequence 53 from Patent EP2369012.
JA526577 - Sequence 220 from Patent EP2369012.
JA526917 - Sequence 53 from Patent EP2369013.
JA527084 - Sequence 220 from Patent EP2369013.
JA535846 - Sequence 53 from Patent EP2371971.
JA536013 - Sequence 220 from Patent EP2371971.
JA779857 - Sequence 7 from Patent EP2419538.
JA787851 - Sequence 53 from Patent EP2479285.
JA788018 - Sequence 220 from Patent EP2479285.
JA788349 - Sequence 53 from Patent EP2479286.
JA788516 - Sequence 220 from Patent EP2479286.
JA810683 - Sequence 53 from Patent EP2468890.
JA810850 - Sequence 220 from Patent EP2468890.
JA811181 - Sequence 53 from Patent EP2468891.
JA811348 - Sequence 220 from Patent EP2468891.
JA811679 - Sequence 53 from Patent EP2468893.
JA811846 - Sequence 220 from Patent EP2468893.
JA812177 - Sequence 53 from Patent EP2468894.
JA812344 - Sequence 220 from Patent EP2468894.
JA812675 - Sequence 53 from Patent EP2468895.
JA812842 - Sequence 220 from Patent EP2468895.
JA813173 - Sequence 53 from Patent EP2468896.
JA813340 - Sequence 220 from Patent EP2468896.
JA813671 - Sequence 53 from Patent EP2468897.
JA813838 - Sequence 220 from Patent EP2468897.
JA814169 - Sequence 53 from Patent EP2468898.
JA814336 - Sequence 220 from Patent EP2468898.
JA814667 - Sequence 53 from Patent EP2468899.
JA814834 - Sequence 220 from Patent EP2468899.
JA816910 - Sequence 53 from Patent EP2468892.
JA817077 - Sequence 220 from Patent EP2468892.
JA825722 - Sequence 53 from Patent EP2471956.
JA825889 - Sequence 220 from Patent EP2471956.
JA826220 - Sequence 53 from Patent EP2471958.
JA826387 - Sequence 220 from Patent EP2471958.
JB024507 - Sequence 53 from Patent EP2505668.
JB024674 - Sequence 220 from Patent EP2505668.
JB025005 - Sequence 53 from Patent EP2505669.
JB025172 - Sequence 220 from Patent EP2505669.
JB079392 - Sequence 53 from Patent EP2487252.
JB079559 - Sequence 220 from Patent EP2487252.
JB079890 - Sequence 53 from Patent EP2487253.
JB080057 - Sequence 220 from Patent EP2487253.
JB080388 - Sequence 53 from Patent EP2487254.
JB080555 - Sequence 220 from Patent EP2487254.
JB080886 - Sequence 53 from Patent EP2487255.
JB081053 - Sequence 220 from Patent EP2487255.
JB081384 - Sequence 53 from Patent EP2487256.
JB081551 - Sequence 220 from Patent EP2487256.
JB081882 - Sequence 53 from Patent EP2487257.
JB082049 - Sequence 220 from Patent EP2487257.
JB082380 - Sequence 53 from Patent EP2487258.
JB082547 - Sequence 220 from Patent EP2487258.
JB082878 - Sequence 53 from Patent EP2487259.
JB083045 - Sequence 220 from Patent EP2487259.
JB083376 - Sequence 53 from Patent EP2487260.
JB083543 - Sequence 220 from Patent EP2487260.
JB083874 - Sequence 53 from Patent EP2487261.
JB084041 - Sequence 220 from Patent EP2487261.
JB084372 - Sequence 53 from Patent EP2487262.
JB084539 - Sequence 220 from Patent EP2487262.
JB084870 - Sequence 53 from Patent EP2487263.
JB085037 - Sequence 220 from Patent EP2487263.
JB087548 - Sequence 53 from Patent EP2502630.
JB087715 - Sequence 220 from Patent EP2502630.
JB147752 - Sequence 53 from Patent EP2484782.
JB147919 - Sequence 220 from Patent EP2484782.
JB148250 - Sequence 53 from Patent EP2484783.
JB148417 - Sequence 220 from Patent EP2484783.
JB152975 - Sequence 53 from Patent EP2514433.
JB153142 - Sequence 220 from Patent EP2514433.
JB153473 - Sequence 53 from Patent EP2514434.
JB153640 - Sequence 220 from Patent EP2514434.
JB622062 - Sequence 53 from Patent EP2586454.
JB622229 - Sequence 220 from Patent EP2586454.
JB622560 - Sequence 53 from Patent EP2586455.
JB622727 - Sequence 220 from Patent EP2586455.
JC001623 - Sequence 53 from Patent EP2591794.
JC001790 - Sequence 220 from Patent EP2591794.
JC221561 - Sequence 36 from Patent EP2471923.
JC221753 - Sequence 228 from Patent EP2471923.
JC268127 - Sequence 36 from Patent EP2471924.
JC268319 - Sequence 228 from Patent EP2471924.
JC340435 - Sequence 36 from Patent EP2471922.
JC340627 - Sequence 228 from Patent EP2471922.
JC469681 - Sequence 36 from Patent EP2471921.
JC469873 - Sequence 228 from Patent EP2471921.
JC571997 - Sequence 11 from Patent EP2759595.
JC990470 - Sequence 36 from Patent EP2808390.
JC990662 - Sequence 228 from Patent EP2808390.
LF132446 - JP 2016506923-A/11: Composition comprising an encapsulated antagomir.
LF714573 - JP 2016165292-A/36: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF714765 - JP 2016165292-A/228: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856507 - JP 2015142597-A/36: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LF856699 - JP 2015142597-A/228: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051544 - KR 1020150036642-A/810: CHIRAL CONTROL.
LG162310 - KR 1020160018451-A/11: Composition comprising an encapsulated antagomir.
LQ654719 - Sequence 6 from Patent WO2016156865.
LQ654750 - Sequence 37 from Patent WO2016156865.
LY480978 - KR 1020170010856-A/241: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495860 - KR 1020170015509-A/239: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496817 - KR 1020170018406-A/687: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497202 - KR 1020170016485-A/372: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498517 - KR 1020170018411-A/434: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ238803 - WO 2017171048-A/464: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869025 - Sequence 239 from Patent EP3156500.
MS884389 - Sequence 372 from Patent EP3156499.
MS994825 - Sequence 687 from Patent EP3159406.
HZ481078 - JP 2015535430-A/1584: TERMINALLY MODIFIED RNA.
HZ791009 - JP 2016504050-A/2754: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JC513741 - Sequence 3994 from Patent WO2014113089.
LQ071329 - Sequence 1653 from Patent EP2964234.
HH981265 - Sequence 25 from Patent EP1723162.
JB256106 - Sequence 25 from Patent EP2327710.
CS548316 - Sequence 1346 from Patent EP1777301.
DJ003788 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027067 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DM119436 - Targeting Cells With Altered miRNA Expression.
FU261457 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763959 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW312057 - DETECTING NUCLEIC ACIDS.
FW418952 - METHOD FOR DISTINGUISHING BETWEEN LUNG SQUAMOUS CARCINOMA AND OTHER NON SMALL CELL LUNG CANCERS.
HI416804 - Sequence 16 from Patent EP2136846.
HV304858 - JP 2009531018-A/425: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305356 - JP 2009531019-A/425: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV954073 - JP 2012518421-A/985: METHODS OF DETECTING LUNG CANCER.
HW064991 - JP 2012528797-A/3: Therapeutic and diagnostic molecules.
HW119565 - JP 2013046612-A/425: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW589894 - JP 2013121348-A/425: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HZ184841 - JP 2015143222-A/3: Therapeutic and diagnostic molecules.
HZ413698 - JP 2014060993-A/425: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ501909 - JP 2016025853-A/425: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
JA526275 - Sequence 425 from Patent EP2369011.
JA526782 - Sequence 425 from Patent EP2369012.
JA527289 - Sequence 425 from Patent EP2369013.
JA536218 - Sequence 425 from Patent EP2371971.
JA715203 - Sequence 985 from Patent EP2401406.
JA788223 - Sequence 425 from Patent EP2479285.
JA788721 - Sequence 425 from Patent EP2479286.
JA811055 - Sequence 425 from Patent EP2468890.
JA811553 - Sequence 425 from Patent EP2468891.
JA812051 - Sequence 425 from Patent EP2468893.
JA812549 - Sequence 425 from Patent EP2468894.
JA813047 - Sequence 425 from Patent EP2468895.
JA813545 - Sequence 425 from Patent EP2468896.
JA814043 - Sequence 425 from Patent EP2468897.
JA814541 - Sequence 425 from Patent EP2468898.
JA815039 - Sequence 425 from Patent EP2468899.
JA817282 - Sequence 425 from Patent EP2468892.
JA826094 - Sequence 425 from Patent EP2471956.
JA826592 - Sequence 425 from Patent EP2471958.
JB024879 - Sequence 425 from Patent EP2505668.
JB025377 - Sequence 425 from Patent EP2505669.
JB079764 - Sequence 425 from Patent EP2487252.
JB080262 - Sequence 425 from Patent EP2487253.
JB080760 - Sequence 425 from Patent EP2487254.
JB081258 - Sequence 425 from Patent EP2487255.
JB081756 - Sequence 425 from Patent EP2487256.
JB082254 - Sequence 425 from Patent EP2487257.
JB082752 - Sequence 425 from Patent EP2487258.
JB083250 - Sequence 425 from Patent EP2487259.
JB083748 - Sequence 425 from Patent EP2487260.
JB084246 - Sequence 425 from Patent EP2487261.
JB084744 - Sequence 425 from Patent EP2487262.
JB085242 - Sequence 425 from Patent EP2487263.
JB087920 - Sequence 425 from Patent EP2502630.
JB148124 - Sequence 425 from Patent EP2484782.
JB148622 - Sequence 425 from Patent EP2484783.
JB153347 - Sequence 425 from Patent EP2514433.
JB153845 - Sequence 425 from Patent EP2514434.
JB358416 - Sequence 3 from Patent EP2438167.
JB622434 - Sequence 425 from Patent EP2586454.
JB622932 - Sequence 425 from Patent EP2586455.
JC001995 - Sequence 425 from Patent EP2591794.
JC334156 - Sequence 74 from Patent EP2487240.
FW301823 - A METHOD OF PRODUCING RECOMBINANT BIOLOGICAL PRODUCTS.
FW364159 - Oligonucleotides for modulating target RNA activity.
HI560837 - Sequence 52 from Patent EP2190992.
HI965243 - Sequence 528 from Patent WO2010139812.
HI966359 - Sequence 679 from Patent WO2010139811.
HI967225 - Sequence 679 from Patent WO2010139810.
HV593938 - JP 2010538653-A/52: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595063 - JP 2010539959-A/444: Micromirs.
HW505531 - JP 2014502606-A/433: MELANOMA TREATMENTS.
HW505554 - JP 2014502606-A/456: MELANOMA TREATMENTS.
HZ073945 - JP 2013535982-A/36: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083149 - JP 2015513906-A/506: Stem Cell Microparticles.
HZ157620 - JP 2015130862-A/444: Micromirs.
HZ186472 - JP 2015146814-A/221: Oligonucleotides for modulating target RNA activity.
HZ436930 - JP 2015529450-A/506: Stem Cell Microparticles.
HZ480000 - JP 2015535430-A/506: TERMINALLY MODIFIED RNA.
HZ789931 - JP 2016504050-A/1676: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA401281 - Sequence 528 from Patent WO2011080318.
JA402259 - Sequence 528 from Patent WO2011080315.
JA403266 - Sequence 528 from Patent WO2011080316.
JA405897 - Sequence 528 from Patent EP2336353.
JA427017 - Sequence 350 from Patent WO2011072177.
JA429423 - Sequence 528 from Patent WO2011095623.
JA660615 - Sequence 69 from Patent WO2011131354.
JA682549 - Sequence 17 from Patent WO2011149354.
JA779859 - Sequence 9 from Patent EP2419538.
JB022352 - Sequence 194 from Patent WO2013026685.
JB022914 - Sequence 168 from Patent WO2013026684.
JB175344 - Sequence 376 from Patent WO2012101219.
JB620057 - Sequence 37 from Patent WO2013063544.
JB620120 - Sequence 100 from Patent WO2013063544.
JB624232 - Sequence 52 from Patent EP2610342.
JC172134 - Sequence 506 from Patent WO2013150303.
JC512663 - Sequence 2916 from Patent WO2014113089.
JC572026 - Sequence 40 from Patent EP2759595.
JC572945 - Sequence 506 from Patent WO2014125276.
JC582633 - Sequence 506 from Patent WO2014125277.
JE954329 - Sequence 506 from Patent WO2015052526.
JE956082 - Sequence 506 from Patent WO2015052527.
JE978624 - Sequence 69 from Patent EP2865765.
LF132475 - JP 2016506923-A/40: Composition comprising an encapsulated antagomir.
LF137834 - JP 2016507550-A/506: Method of Producing Microparticles.
LF160855 - JP 2016513950-A/921: Oligomers with improved off-target profile.
LF162799 - JP 2016513095-A/506: Stem Cell Microparticles and miRNA.
LF953551 - JP 2016534103-A/506: Stem Cell Microparticles and miRNA.
LG005896 - KR 1020150004822-A/506: STEM CELL MICROPARTICLES.
LG053592 - KR 1020150059168-A/506: STEM CELL MICROPARTICLES.
LG162339 - KR 1020160018451-A/40: Composition comprising an encapsulated antagomir.
LG240831 - KR 1020160035087-A/506: STEM CELL MICROPARTICLES AND MIRNA.
LP726985 - Sequence 679 from Patent EP2883966.
LP819255 - Sequence 679 from Patent EP3296406.
LP939197 - Sequence 679 from Patent EP3184651.
LQ070251 - Sequence 575 from Patent EP2964234.
LV470916 - JP 2016534036-A/506: Stem Cell Microparticles and miRNA.
LX146815 - JP 2017506638-A/8: Compositions and Methods for Treating Liver Injury.
LY405128 - KR 1020160117535-A/433: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233829 - JP 2017184756-A/221: Oligonucleotides for modulating target RNA activity.
MA260367 - JP 2017505623-A/433: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673365 - Sequence 168 from Patent EP3135774.
MS816874 - Sequence 223 from Patent WO2017085287.
MS833347 - Sequence 52 from Patent EP3112464.
MS834382 - Sequence 528 from Patent EP3112479.
MS901721 - Sequence 194 from Patent EP3156505.
JA779858 - Sequence 8 from Patent EP2419538.
HZ460386 - WO 2015190542-A/392: Kit or device and method for detecting biliary tract cancer.
HZ461773 - WO 2015190586-A/586: Kit and method for detecting colon cancer.
HZ464884 - WO 2015194615-A/702: Kit or device and method for detecting hepatic cancer.
HZ465646 - WO 2015194627-A/699: Kit and method for detecting esophageal cancer.
LY496013 - KR 1020170015509-A/392: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496829 - KR 1020170018406-A/699: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497416 - KR 1020170016485-A/586: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498785 - KR 1020170018411-A/702: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ239090 - WO 2017171048-A/751: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MS869178 - Sequence 392 from Patent EP3156500.
MS884603 - Sequence 586 from Patent EP3156499.
MS994837 - Sequence 699 from Patent EP3159406.
HZ481079 - JP 2015535430-A/1585: TERMINALLY MODIFIED RNA.
HZ791010 - JP 2016504050-A/2755: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JC513742 - Sequence 3995 from Patent WO2014113089.
LQ071330 - Sequence 1654 from Patent EP2964234.
HZ459639 - WO 2015182781-A/342: Kit or device and method for detecting pancreatic cancer.
LY481079 - KR 1020170010856-A/342: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
AF480527 - Homo sapiens microRNA miR-24 gene, complete sequence.
AJ421744 - Homo sapiens microRNA miR-24-1.
AJ421745 - Homo sapiens microRNA miR-24-2.
CQ873612 - Sequence 31 from Patent WO2004076622.
CS083366 - Sequence 100 from Patent WO2005040419.
CS166315 - Sequence 26 from Patent WO2005078096.
CS265284 - Sequence 26 from Patent EP1627925.
CS265285 - Sequence 27 from Patent EP1627925.
CS417784 - Sequence 12 from Patent WO2006048553.
CS444339 - Sequence 26 from Patent WO2006108473.
CS444340 - Sequence 27 from Patent WO2006108473.
CS548368 - Sequence 1398 from Patent EP1777301.
DD413449 - Regulation of Mammalian Cells.
DI443421 - KR 1020140074997-A/42: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DI443422 - KR 1020140074997-A/43: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
DJ003813 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027092 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ061812 - Oligonucleotide Microarray.
DL231856 - Method for the determination of cellular transcriptional regulation.
DL231857 - Method for the determination of cellular transcriptional regulation.
DL233845 - Identification of novel genes encoding for small temporal RNA.
DL243014 - Agent for controlling growth and/or differentiation of mesenchymal stem cells.
DM119435 - Targeting Cells With Altered miRNA Expression.
DM119438 - Targeting Cells With Altered miRNA Expression.
DM174418 - A nucleics Acid regulating cell growth.
FU261369 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763871 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV523074 - Identification of novel genes encoding for small temporal RNA.
FV524268 - Nucleic acid controling mast cell degranulation.
FW312109 - DETECTING NUCLEIC ACIDS.
FW364158 - Oligonucleotides for modulating target RNA activity.
FZ413529 - WO 2011001906-A/2: Method for evaluation of cultured cells.
FZ414355 - WO 2011007815-A/245: A method for screening a food which promotes production of milk having immunoregulating effect.
HI548974 - Sequence 37 from Patent EP2187900.
HI560836 - Sequence 51 from Patent EP2190992.
HI560838 - Sequence 53 from Patent EP2190992.
HI965244 - Sequence 529 from Patent WO2010139812.
HI966038 - Sequence 358 from Patent WO2010139811.
HI966904 - Sequence 358 from Patent WO2010139810.
HV304770 - JP 2009531018-A/337: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305268 - JP 2009531019-A/337: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV538907 - JP 2011211955-A/3: Composition and method for prediction of prognosis of patients with hepatoma.
HV593937 - JP 2010538653-A/51: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV593939 - JP 2010538653-A/53: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595062 - JP 2010539959-A/443: Micromirs.
HV821883 - JP 2011140513-A/245: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV953939 - JP 2012518421-A/851: METHODS OF DETECTING LUNG CANCER.
HW060385 - JP 2012527478-A/49: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure.
HW119477 - JP 2013046612-A/337: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW122368 - JP 2013504331-A/27: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
HW151487 - WO 2013047815-A/32: ENDOPLASMIC RETICULUM STRESS MODULATOR.
HW413600 - WO 2014003053-A/49: Method for screening pancreatic cancer and test kit therefor.
HW503022 - WO 2014034685-A/1: Diagnosis of Rheumatoid Arthritis by MicroRNA.
HW505369 - JP 2014502606-A/271: MELANOMA TREATMENTS.
HW505370 - JP 2014502606-A/272: MELANOMA TREATMENTS.
HW505400 - JP 2014502606-A/302: MELANOMA TREATMENTS.
HW523268 - JP 2014507123-A/53: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS.
HW530030 - JP 2014094008-A/91: Identification of novel genes encoding for small temporal RNA.
HW589806 - JP 2013121348-A/337: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW798895 - WO 2014192907-A/1: Method for detecting miRNA used for differentiating disorders causing motor neuropathy.
HW807747 - JP 2014534810-A/42: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HW807748 - JP 2014534810-A/43: MICRORNAS IN NEURODEGENERATIVE DISORDERS.
HZ073946 - JP 2013535982-A/37: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082762 - JP 2015513906-A/119: Stem Cell Microparticles.
HZ157619 - JP 2015130862-A/443: Micromirs.
HZ186471 - JP 2015146814-A/220: Oligonucleotides for modulating target RNA activity.
HZ413610 - JP 2014060993-A/337: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ436543 - JP 2015529450-A/119: Stem Cell Microparticles.
HZ459415 - WO 2015182781-A/118: Kit or device and method for detecting pancreatic cancer.
HZ460083 - WO 2015190542-A/89: Kit or device and method for detecting biliary tract cancer.
HZ461367 - WO 2015190586-A/180: Kit and method for detecting colon cancer.
HZ464397 - WO 2015194615-A/215: Kit or device and method for detecting hepatic cancer.
HZ465623 - WO 2015194627-A/676: Kit and method for detecting esophageal cancer.
HZ480002 - JP 2015535430-A/508: TERMINALLY MODIFIED RNA.
HZ501821 - JP 2016025853-A/337: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ789933 - JP 2016504050-A/1678: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
HZ883159 - JP 2016065089-A/21: Therapeutic Compositions For Treatment of Inflammation of Ocular and Adnexal Tissues.
JA401282 - Sequence 529 from Patent WO2011080318.
JA402260 - Sequence 529 from Patent WO2011080315.
JA403267 - Sequence 529 from Patent WO2011080316.
JA405898 - Sequence 529 from Patent EP2336353.
JA426922 - Sequence 255 from Patent WO2011072177.
JA429424 - Sequence 529 from Patent WO2011095623.
JA526187 - Sequence 337 from Patent EP2369011.
JA526694 - Sequence 337 from Patent EP2369012.
JA527201 - Sequence 337 from Patent EP2369013.
JA536130 - Sequence 337 from Patent EP2371971.
JA641971 - Sequence 91 from Patent EP2386637.
JA663256 - Sequence 91 from Patent EP2385122.
JA663473 - Sequence 91 from Patent EP2385123.
JA682626 - Sequence 94 from Patent WO2011149354.
JA715069 - Sequence 851 from Patent EP2401406.
JA779855 - Sequence 5 from Patent EP2419538.
JA788135 - Sequence 337 from Patent EP2479285.
JA788633 - Sequence 337 from Patent EP2479286.
JA791885 - Sequence 287 from Patent WO2012089772.
JA792180 - Sequence 229 from Patent WO2012089753.
JA792322 - Sequence 37 from Patent WO2012089630.
JA810967 - Sequence 337 from Patent EP2468890.
JA811465 - Sequence 337 from Patent EP2468891.
JA811963 - Sequence 337 from Patent EP2468893.
JA812461 - Sequence 337 from Patent EP2468894.
JA812959 - Sequence 337 from Patent EP2468895.
JA813457 - Sequence 337 from Patent EP2468896.
JA813955 - Sequence 337 from Patent EP2468897.
JA814453 - Sequence 337 from Patent EP2468898.
JA814951 - Sequence 337 from Patent EP2468899.
JA817194 - Sequence 337 from Patent EP2468892.
JA826006 - Sequence 337 from Patent EP2471956.
JA826504 - Sequence 337 from Patent EP2471958.
JA878992 - Sequence 7 from Patent EP2460877.
JA885423 - Sequence 53 from Patent WO2012083004.
JB022648 - Sequence 490 from Patent WO2013026685.
JB024417 - Sequence 37 from Patent EP2505663.
JB024791 - Sequence 337 from Patent EP2505668.
JB025289 - Sequence 337 from Patent EP2505669.
JB074896 - Sequence 156 from Patent WO2012168448.
JB079676 - Sequence 337 from Patent EP2487252.
JB080174 - Sequence 337 from Patent EP2487253.
JB080672 - Sequence 337 from Patent EP2487254.
JB081170 - Sequence 337 from Patent EP2487255.
JB081668 - Sequence 337 from Patent EP2487256.
JB082166 - Sequence 337 from Patent EP2487257.
JB082664 - Sequence 337 from Patent EP2487258.
JB083162 - Sequence 337 from Patent EP2487259.
JB083660 - Sequence 337 from Patent EP2487260.
JB084158 - Sequence 337 from Patent EP2487261.
JB084656 - Sequence 337 from Patent EP2487262.
JB085154 - Sequence 337 from Patent EP2487263.
JB087832 - Sequence 337 from Patent EP2502630.
JB148036 - Sequence 337 from Patent EP2484782.
JB148534 - Sequence 337 from Patent EP2484783.
JB149170 - Sequence 245 from Patent EP2455486.
JB153259 - Sequence 337 from Patent EP2514433.
JB153757 - Sequence 337 from Patent EP2514434.
JB174987 - Sequence 19 from Patent WO2012101219.
JB233517 - Sequence 49 from Patent EP2437750.
JB235846 - Sequence 2 from Patent EP2450454.
JB249303 - Sequence 71 from Patent EP2478360.
JB292053 - Sequence 91 from Patent EP2428569.
JB302168 - Sequence 91 from Patent EP2428570.
JB320123 - Sequence 91 from Patent EP2428568.
JB336186 - Sequence 91 from Patent EP2428571.
JB361373 - Sequence 91 from Patent EP2428567.
JB616184 - Sequence 14 from Patent WO2013107459.
JB620121 - Sequence 101 from Patent WO2013063544.
JB621209 - Sequence 2 from Patent WO2013063519.
JB622346 - Sequence 337 from Patent EP2586454.
JB622844 - Sequence 337 from Patent EP2586455.
JB624231 - Sequence 51 from Patent EP2610342.
JB624233 - Sequence 53 from Patent EP2610342.
JC001907 - Sequence 337 from Patent EP2591794.
JC019935 - Sequence 2 from Patent EP2644706.
JC032732 - Sequence 4 from Patent WO2013160474.
JC037766 - Sequence 294 from Patent EP2643479.
JC171747 - Sequence 119 from Patent WO2013150303.
JC244422 - Sequence 42 from Patent WO2012020308.
JC244874 - Sequence 502 from Patent WO2012020308.
JC334200 - Sequence 118 from Patent EP2487240.
JC512665 - Sequence 2918 from Patent WO2014113089.
JC572025 - Sequence 39 from Patent EP2759595.
JC572027 - Sequence 41 from Patent EP2759595.
JC572558 - Sequence 119 from Patent WO2014125276.
JC582246 - Sequence 119 from Patent WO2014125277.
JD568634 - Sequence 5 from Patent WO2015007871.
JD587470 - Sequence 3 from Patent EP2825885.
JE829078 - Sequence 14 from Patent EP2829613.
JE844306 - Sequence 49 from Patent WO2015091897.
JE846313 - Sequence 15 from Patent WO2015095862.
JE953942 - Sequence 119 from Patent WO2015052526.
JE955695 - Sequence 119 from Patent WO2015052527.
JE957369 - Sequence 1 from Patent EP2889383.
JE998706 - Sequence 26 from Patent WO2015114469.
LF132474 - JP 2016506923-A/39: Composition comprising an encapsulated antagomir.
LF132476 - JP 2016506923-A/41: Composition comprising an encapsulated antagomir.
LF137447 - JP 2016507550-A/119: Method of Producing Microparticles.
LF161184 - JP 2016513950-A/1250: Oligomers with improved off-target profile.
LF162412 - JP 2016513095-A/119: Stem Cell Microparticles and miRNA.
LF632729 - WO 2016117582-A/158: miRNA biomarkers for mental disorders.
LF636240 - JP 2016519076-A/14: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953164 - JP 2016534103-A/119: Stem Cell Microparticles and miRNA.
LG005509 - KR 1020150004822-A/119: STEM CELL MICROPARTICLES.
LG046490 - KR 1020150023687-A/35: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif.
LG053205 - KR 1020150059168-A/119: STEM CELL MICROPARTICLES.
LG134397 - KR 1020150131312-A/14: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG162338 - KR 1020160018451-A/39: Composition comprising an encapsulated antagomir.
LG162340 - KR 1020160018451-A/41: Composition comprising an encapsulated antagomir.
LG240444 - KR 1020160035087-A/119: STEM CELL MICROPARTICLES AND MIRNA.
LP061540 - Sequence 6 from Patent WO2015032789.
LP643846 - Sequence 4 from Patent WO2015091892.
LP726664 - Sequence 358 from Patent EP2883966.
LP769563 - Sequence 90 from Patent EP3294910.
LP803864 - Sequence 3 from Patent EP3266881.
LP818934 - Sequence 358 from Patent EP3296406.
LP896971 - Sequence 1835 from Patent EP3253886.
LP917438 - Sequence 34 from Patent WO2017153710.
LP938876 - Sequence 358 from Patent EP3184651.
LP951561 - Sequence 67 from Patent WO2017157650.
LQ070253 - Sequence 577 from Patent EP2964234.
LQ420471 - Sequence 47 from Patent WO2016127998.
LQ441149 - Sequence 156 from Patent EP3029157.
LQ654718 - Sequence 5 from Patent WO2016156865.
LQ664854 - Sequence 43 from Patent WO2016150475.
LQ724578 - Sequence 211 from Patent WO2018096084.
LQ840925 - Sequence 35 from Patent EP3354734.
LQ844114 - Sequence 34 from Patent WO2018138468.
LQ859730 - Sequence 6 from Patent EP3360977.
LV470529 - JP 2016534036-A/119: Stem Cell Microparticles and miRNA.
LV746110 - JP 2015521626-A/35: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
LX058147 - JP 2011516400-A/21: Therapeutic Compositions For Treatment of Inflammation of Ocular and Adnexal Tissues.
LX146816 - JP 2017506638-A/9: Compositions and Methods for Treating Liver Injury.
LX280740 - JP 2016105097-A/27: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LY405127 - KR 1020160117535-A/432: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY416938 - KR 1020160145093-A/44: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY.
LY480855 - KR 1020170010856-A/118: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
LY495710 - KR 1020170015509-A/89: DETECTION KIT OR DEVICE AND DETECTION METHOD FOR BILIARY TRACT CANCER.
LY496806 - KR 1020170018406-A/676: ESOPHAGEAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY497010 - KR 1020170016485-A/180: COLORECTAL CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LY498298 - KR 1020170018411-A/215: LIVER CANCER DETECTION KIT OR DEVICE, AND DETECTION METHOD.
LZ233828 - JP 2017184756-A/220: Oligonucleotides for modulating target RNA activity.
LZ234358 - JP 2017181518-A/27: MICRO-RNA, AUTOANTIBODY AND PROTEIN MARKERS FOR DIAGNOSIS OF NEURONAL INJURY.
LZ238544 - WO 2017171048-A/205: Kit, device and method for detecting early pancreatic cancer or precancerous lesion of pancreas.
MA260366 - JP 2017505623-A/432: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MA265111 - JP 2017502661-A/26: Covered Sequence Conversion DNA and Detection Methods.
MS637972 - Sequence 89 from Patent WO2017037190.
MS833346 - Sequence 51 from Patent EP3112464.
MS833348 - Sequence 53 from Patent EP3112464.
MS834383 - Sequence 529 from Patent EP3112479.
MS868875 - Sequence 89 from Patent EP3156500.
MS884197 - Sequence 180 from Patent EP3156499.
MS902017 - Sequence 490 from Patent EP3156505.
MS994814 - Sequence 676 from Patent EP3159406.
HZ459638 - WO 2015182781-A/341: Kit or device and method for detecting pancreatic cancer.
LY481078 - KR 1020170010856-A/341: PANCREATIC CANCER DETECTION KIT, DEVICE, AND DETECTION METHOD.
MA643750 - JP 2017113010-A/1674: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731634 - JP 2017140048-A/504: TERMINALLY MODIFIED RNA.
MA643749 - JP 2017113010-A/1673: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731633 - JP 2017140048-A/503: TERMINALLY MODIFIED RNA.
MA643771 - JP 2017113010-A/1695: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731655 - JP 2017140048-A/525: TERMINALLY MODIFIED RNA.
MA643770 - JP 2017113010-A/1694: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731654 - JP 2017140048-A/524: TERMINALLY MODIFIED RNA.
MA644830 - JP 2017113010-A/2754: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA732714 - JP 2017140048-A/1584: TERMINALLY MODIFIED RNA.
MA643752 - JP 2017113010-A/1676: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731636 - JP 2017140048-A/506: TERMINALLY MODIFIED RNA.
MA644831 - JP 2017113010-A/2755: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA732715 - JP 2017140048-A/1585: TERMINALLY MODIFIED RNA.
MA643754 - JP 2017113010-A/1678: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731638 - JP 2017140048-A/508: TERMINALLY MODIFIED RNA.
MA765584 - JP 2017514519-A/150: Small ncRNAs as biomarkers.
MA765554 - JP 2017514519-A/120: Small ncRNAs as biomarkers.
MA765585 - JP 2017514519-A/151: Small ncRNAs as biomarkers.
MA400874 - JP 2018515097-A/61: Method for Diagnosis and Prognosis of Chronic Heart Failure.
MA400850 - JP 2018515097-A/37: Method for Diagnosis and Prognosis of Chronic Heart Failure.
MA400903 - JP 2018515097-A/90: Method for Diagnosis and Prognosis of Chronic Heart Failure.
LQ978384 - Sequence 11 from Patent WO2013040251.
MA405554 - WO 2018155427-A/328: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA405435 - WO 2018155427-A/209: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MP070483 - Sequence 80 from Patent WO2018231851.
MP075708 - Sequence 47 from Patent WO2019002265.
MP084327 - Sequence 479 from Patent EP3401393.
MP015450 - Sequence 653 from Patent WO2019016252.
MP070473 - Sequence 70 from Patent WO2018231851.
MP075710 - Sequence 49 from Patent WO2019002265.
MP075709 - Sequence 48 from Patent WO2019002265.
MP014868 - Sequence 71 from Patent WO2019016252.
MP070421 - Sequence 18 from Patent WO2018231851.
MP075682 - Sequence 21 from Patent WO2019002265.
MA806284 - WO 2018199275-A/544: Kit, device and method for detection of ovary tumor.
MA800803 - JP 2018183181-A/1674: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA806576 - WO 2018199275-A/836: Kit, device and method for detection of ovary tumor.
MA800802 - JP 2018183181-A/1673: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA806012 - WO 2018199275-A/272: Kit, device and method for detection of ovary tumor.
MA800824 - JP 2018183181-A/1695: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800823 - JP 2018183181-A/1694: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA806282 - WO 2018199275-A/542: Kit, device and method for detection of ovary tumor.
MA801883 - JP 2018183181-A/2754: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800805 - JP 2018183181-A/1676: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA806574 - WO 2018199275-A/834: Kit, device and method for detection of ovary tumor.
MA801884 - JP 2018183181-A/2755: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA800807 - JP 2018183181-A/1678: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA806011 - WO 2018199275-A/271: Kit, device and method for detection of ovary tumor.
MA822721 - WO 2019004436-A/534: Kit, device, and method for detection of lung cancer.
MP129610 - Sequence 510 from Patent EP3470073.
MP162533 - Sequence 510 from Patent WO2019069093.
MA823044 - WO 2019004436-A/857: Kit, device, and method for detection of lung cancer.
MA822384 - WO 2019004436-A/197: Kit, device, and method for detection of lung cancer.
MP129159 - Sequence 59 from Patent EP3470073.
MP162082 - Sequence 59 from Patent WO2019069093.
MP129301 - Sequence 201 from Patent EP3470073.
MP162224 - Sequence 201 from Patent WO2019069093.
MP129106 - Sequence 6 from Patent EP3470073.
MP162029 - Sequence 6 from Patent WO2019069093.
MA822722 - WO 2019004436-A/535: Kit, device, and method for detection of lung cancer.
MP129606 - Sequence 506 from Patent EP3470073.
MP162529 - Sequence 506 from Patent WO2019069093.
MA823046 - WO 2019004436-A/859: Kit, device, and method for detection of lung cancer.
MA822385 - WO 2019004436-A/198: Kit, device, and method for detection of lung cancer.
MP129219 - Sequence 119 from Patent EP3470073.
MP162142 - Sequence 119 from Patent WO2019069093.
MB018417 - JP 2018504915-A/46: A microRNA-based method for early detection of prostate cancer in urine samples.
MB017902 - JP 2018506997-A/34: SIGNATURE OF HEALTH.
MB018421 - JP 2018504915-A/50: A microRNA-based method for early detection of prostate cancer in urine samples.
MA896092 - JP 2017217007-A/35: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
MB018418 - JP 2018504915-A/47: A microRNA-based method for early detection of prostate cancer in urine samples.
MP242815 - Sequence 19 from Patent EP3476951.
MP262578 - Sequence 82 from Patent EP3524679.
MP262580 - Sequence 84 from Patent EP3524679.
MP280619 - Sequence 39 from Patent WO2019111197.
MP264448 - Sequence 36 from Patent EP3502269.
MP280614 - Sequence 34 from Patent WO2019111197.
MP272066 - Sequence 14 from Patent WO2019157381.
MP272067 - Sequence 15 from Patent WO2019157381.
MP283532 - Sequence 39 from Patent WO2019111198.
MP272061 - Sequence 9 from Patent WO2019157381.
MP283527 - Sequence 34 from Patent WO2019111198.
LY616431 - KR 1020180129785-A/328: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616702 - KR 1020180129785-A/599: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616179 - KR 1020180129785-A/76: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616567 - KR 1020180129785-A/464: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616854 - KR 1020180129785-A/751: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.
LY616308 - KR 1020180129785-A/205: KIT OR DEVICE FOR DETECTING EARLY STAGE PANCREATIC CANCER OR PANCREATIC CANCER PRECURSOR LESIONS AND DETECTION METHOD THEREFOR.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029496
UCSC ID: uc004avg.4
RefSeq Accession: NR_029664

-  Gene Model Information
 
category: noncoding nonsense-mediated-decay: no RNA accession: NR_029496.1
exon count: 1CDS single in 3' UTR: no RNA size: 68
ORF size: 0CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 452.00frame shift in genome: no % Coverage: 100.00
has start codon: no stop codon in genome: no # of Alignments: 1
has end codon: no retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.